Top

Mark E. Zafereo, M.D., F.A.C.S.

Department of Head and Neck Surgery, Division of Surgery

About Dr. Zafereo

Dr. Mark Zafereo is a Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas where he is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Head & Neck Center. Dr. Zafereo serves on the Board of American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), and the Board of the International Thyroid Oncology Group (ITOG). He holds national committee appointments for AAO-HNS, ITOG, American Head and Neck Society, American Thyroid Association, and American College of Surgeons. Dr. Zafereo leads several national multicenter clinical trials on neoadjuvant therapy followed by surgery for anaplastic and medullary thyroid cancers. He has published significantly on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.

Meet Mark Zafereo, M.D.

In the News

Present Title & Affiliation

Primary Appointment

Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Adjunct Faculty Appointment, Baylor College of Medicine, Houston, TX

Dual/Joint/Adjunct Appointment

Professor with tenure, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Adjunct Faculty Appointment, Baylor College of Medicine, Houston, TX

Education & Training

Degree-Granting Education

2005	University of Texas Medical School, Houston, Texas, US, MD
2001	University of Texas, Austin, Texas, US, Finance, BBA

Postgraduate Training

2022-2022	Weatherhead Executive Education School of Management in Partnership, MD Anderson Cancer Center Leadership Institute Emotional Intelligence Certificate Program, Case Western Reserve University Weatherhead School of Management, Houston, Texas
2021-2022	LEADing Others Accelerate Program, University of Texas MD Anderson Cancer Center Leadership Institute, Houston, Texas
2020-2020	LEADing Others Core Curriculum, University of Texas MD Anderson Cancer Center Leadership Institute, Houston, Texas
2010-2011	Clinical Fellowship, Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas
2007-2010	Clinical Residency, Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas
2005-2007	Clinical Residency, Otolaryngology-Head and Neck Surgery, University of Texas Health Science Center, Houston, Texas

Board Certifications

2011	American Board of Otolaryngology

Experience & Service

Academic Appointments

Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2024

Associate Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2021

Assistant Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2016

Clinical Specialist, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2011

Administrative Appointments/Responsibilities

Associate Medical Director, Head & Neck Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

Director, Department of Head and Neck Surgery Visiting Professor Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2022

Section Chief, Department of Head and Neck Endocrine Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

Associate Medical Director, Department of Endocrine Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2021

Director, Department of Head and Neck Surgery International Visiting Scientist and Observer Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2024

Back-up Moderator, Department of Weekly Multidisciplinary Head and Neck Planning Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present

Faculty Oversight, Department of Head and Neck Survivorship Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2016

Institutional Committee Activities

Chair, Clinical Faculty Appointment Progress Review Committee for Dr. Ranjit Nair, 2022 - 2022

Chair, Clinical Faculty Appointment Progress Review Committee for Dr. Jennifer R. Wang, 2022 - 2022

Member, Ambulatory Core Clinical Leadership Team (A-CCLT), 2022 - Present

Chair, Clinical Faculty Appointment Progress Review for Ryan Goepfert, MD, 2021 - 2021

Member, Search Committee for Head & Neck Faculty Recruitment, 2021 - 2021

Member, Search Committee for Advanced Practice Manager Recruitment, 2021 - 2021

Member, Perioperative Communications Workgroup, 2018 - 2018

Chair, Search Committee for Head & Neck Endocrine Section Faculty Recruitment, 2018 - 2018

Member, Endocrine Center Steering Committee, 2015 - Present

Member, Endocrine Center Epic Specialty Content Validation Workgroup, 2014 - 2016

Member, MD Anderson Division of Surgery Cancer Network Operations Committee, 2014 - 2018

Member, Global Academic Programs Africa Steering Committee, 2012 - 2019

Honors & Awards

	University of Texas Magna cum Laude, University Honors
	Alpha Omega Alpha Honor Medical Society
	Memorial Hermann Hospital Medical Humanitarian Grant
	American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting Resident Leadership Grant
	American Head and Neck Society 7th International Conference on Head and Neck Cancer Grant
	American Academy of Otolaryngology-Head and Neck Surgery Foundation Board of Governors Resident Leadership Grant
	Houston Society of Otolaryngology-Head and Neck Surgery Research Award
	Houston Surgical Society Research Award
	Combined Otolaryngology Society Meeting Distinguished Poster and American Head and Neck Society Presidential Citation
	American Association for Cancer Research Scholar-In-Training Award Finalist
	Texas Association of Otolaryngology Research Award
	Hitoshi Nikaidoh Memorial Humanitarian Grant
	Global ENT Outreach Farhangi/Asdaghi Scholarship for International Medical Service Projects
	American Academy of Otolaryngology-Head and Neck Surgery Foundation Board of Governors Spring Meeting Resident Leadership Grant
	American Academy of Otolaryngology-Head and Neck Surgery Humanitarian Grant
	American Academy of Otolaryngology-Head and Neck Surgery Foundation Spring Meeting Resident Leadership Grant
	Texas Super Doctors
	American Academy of Otolaryngology-Head and Neck Surgery Holt Leadership Award
	Tanzanian ENT Society Honorary Member
	American Academy of Otolaryngology-Head and Neck Surgery Honor Service Award
	American Academy of Otolaryngology-Head and Neck Surgery Nominating Committee Candidate
	American Academy of Otolaryngology-Head and Neck Surgery Young Physicians Spotlight
	Committee Excellence Award for Distinguished Service on the Humanitarian Efforts Committee
	American Academy of Otolaryngology-Head and Neck Surgery Committee Excellence Award for Distinguished Service on the Humanitarian Efforts Committee
	Baylor College of Medicine Inaugural Donald T. Donovan Excellence in Resident Education Award
	MD Anderson Cancer Center Top Performer Award (based on Consumer Assessment of Healthcare Providers and Systems Top 1% nationally), University of Texas MD Anderson Cancer Center
	American Academy of Otolaryngology-Head and Neck Surgery Arnold P. Gold Foundation Award for Humanism in Medicine
	American Head and Neck Society 2017 COSM Distinguished Poster
	American Academy of Otolaryngology-Head and Neck Surgery Board of Governors Practitioner Excellence Award
	Distinguished Educator of the Year Award, MD Anderson Cancer Center - Department of Head and Neck Surgery
	MD Anderson Cancer Center Top Performer Award (based on Consumer Assessment of Healthcare Providers and Systems Top 10% nationally)
	Distinguished Educator of the Year Award, MD Anderson Cancer Center - Dept. of Head and Neck Surgery
	Distinguished Educator of the Year Award, MD Anderson Cancer Center - Department of Head and Neck Surgery
	American Academy of Otolaryngology-Head and Neck Surgery Distinguished Service Award
	American Head and Neck Society 2022 Annual Meeting Best Poster
	American Thyroid Association - 2023 Van Meter Award
	Castle Connolly Top Doctors

Selected Publications

Peer-Reviewed Articles

Sun P, Gu KJ, Zheng G, Sikora AG, Li C, Zafereo M, Wei P, Wu J, Shete S, Liu J, Li G. Genetic variations associated with telomere length predict the risk of recurrence of non-oropharyngeal head and neck squamous cell carcinoma. Mol Carcinog 63(9):1722-1737, 2024. PMID: 38837510.
Szabo Yamashita T, Williams-Perez SM, Ehsan S, Mulder M, Kronenfeld D, Huang CY, Zhao H, Merriman K, Peterson SK, Hu MI, Zafereo M, Sosa JA, Grubbs EG. The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?. Thyroid 34(9):1117-1125, 2024. PMID: 38984944.
Castellanos LE, Zafereo ME, Sturgis EM, Wang JR, Ying AK, Waguespack SG. Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine. J Clin Endocrinol Metab None(None):None, 2024. PMID: 39163248.
Wang JR, Zafereo ME, Cabanillas ME, Wu CC, Xu L, Dai Y, Wang W, Lai SY, Henderson Y, Erasmus L, Williams MD, Joshu C, Ray D. The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma. J Clin Endocrinol Metab None(None):None, 2024. PMID: 39087944.
Yang Z, Mansour J, Sun P, Wei P, Dahlstrom KR, Zafereo ME, Li G, Gross ND. Impact of pretreatment body mass index on the survival of head and neck cancer patients. Head Neck 46(8):1881-1892, 2024. e-Pub 2024. PMID: 38269627.
Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol None(None):None, 2024. PMID: 38990526.
Liu W, Ding Z, Tao Y, Liu S, Jiang M, Yi F, Wang Z, Han Y, Zong H, Li D, Zhu Y, Xie Z, Sang S, Chen X, Miao M, Chen X, Lin W, Zhao Y, Zheng G, Zafereo M, Li G, Wu J, Zha X, Liu Y. A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression. Mol Cancer 23(1):141, 2024. PMID: 38982480.
Russell MD, Abdelhamid Ahmed AH, Feng Z, Shonka DC, Karcioglu AS, Iwata AJ, Kyriazidis N, Siddiqui SH, Athni TS, Park JC, Wirth LJ, Zafereo ME, Randolph GW. Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization. Laryngoscope 134(7):3415-3419, 2024. e-Pub 2024. PMID: 38264976.
Shirali AS, Hu MI, Chiang YJ, Graham PH, Fisher SB, Sosa JA, Perrier N, Brown S, Holla VR, Dadu R, Busaidy N, Sherman SI, Cabanillas M, Waguespack SG, Zafereo ME, Grubbs EG. Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness. J Endocr Soc 8(6):bvae048, 2024. e-Pub 2024. PMID: 38660141.
Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid 34(3):336-346, 2024. e-Pub 2024. PMID: 38226606.
Niu Z, Sun P, Zafereo ME, Liu H, Wei P, Wu J, Gross ND, Shete S, Wei Q, Zheng G, Sikora AG, Calin GA, Li G. TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation. Cancer Immunol Immunother 73(5):85, 2024. e-Pub 2024. PMID: 38554185.
Hensley SG, Hu MI, Bassett RL, Ying AK, Zafereo ME, Perrier ND, Busaidy NL, Hyde SM, Grubbs EG, Waguespack SG. Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades. J Clin Endocrinol Metab. e-Pub 2024. PMID: 38441533.
Hawes EE, Cabanillas ME, Hutcheson K, Barbon C, Dadu R, Busaidy NL, Iyer PC, Siddiqui SH, Maniakas A, Wang JR, Zafereo ME. Recurrent Laryngeal Nerve Recovery After Neoadjuvant Therapy for BRAF-Mutated Anaplastic Thyroid Cancer. VideoEndocrinology 11(1):13-15, 2024. e-Pub 2024. PMID: None.
Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo ME. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck 46(2):328-335, 2024. e-Pub 2023. PMID: 38009416.
Rao KN, Rajguru R, Dange P, Vetter D, Triponez F, Nixon IJ, Randolph GW, Mäkitie AA, Zafereo ME, Ferlito A. Lower Rates of Hypocalcemia Following Near-Infrared Autofluorescence Use in Thyroidectomy: A Meta-Analysis of RCTs. Diagnostics (Basel) 14(5), 2024. e-Pub 2024. PMID: 38472977.
Mohamed ASR, Martin GV, Ng SP, Takiar V, Beadle BM, Zafereo ME, Garden AS, Frank SJ, David Fuller C, Brandon Gunn G, Morrison WH, Rosenthal DI, Reddy J, Moreno A, Lee A, Phan J. Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation. Clin Transl Radiat Oncol 44:100700, 2024. e-Pub 2023. PMID: 38058404.
Rao, KN, Arora, R, Dange, P, Nagarkar, N, Mäkitie, AA, Kowalski, LP, Eisbruch, A, Hamoir, M, Civantos, F, Vander Poorten, V, Ng, SP, Nuyts, S, Zafereo, M, Asarkar, AA, Golusinski, P, Ronen, O, Ferlito, A. A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers. Oncology and Therapy 11(4):461-480, 2023. PMID: 37804420.
Zheng G, Zhang H, Lin F, Zafereo ME, Gross N, Sun P, Liu Y, Sun H, Wu G, Wei S, Wu J, Mao N, Li G, Wu G, Zheng H, Song X. Performance of CT-based deep learning in diagnostic assessment of suspicious laternal lymphnodes in papillary thyroid cancer: A Prospective Diagnostic Study. Int J Surg 109(11):3337-3345, 2023. e-Pub 2023. PMID: 37578434.
Silver Karcioglu A, Abdelhamid Ahmed AH, Feng Z, Russell M, Shonka DC, Iwata A, Cabanillas M, Shin JJ, Kyriazidis N, Park JC, Wirth LJ, Zafereo ME, Randolph GW. Return of Vocal Fold Motion and Surgical Preservation of Invaded Recurrent Laryngeal Nerves After the Use of Neoadjuvant Therapy in Patients Presenting with Advanced Thyroid Cancer and Vocal Fold Paralysis: The Lazarus Effect. Thyroid 33(10):1259-1263, 2023. PMID: 37694677.
Sanabria A, Olivera MP, Chiesa-Estomba C, Hamoir M, Kowalski LP, López F, Mäkitie A, Robbins KT, Rodrigo JP, Piazza C, Shaha A, Sjögren E, Suarez C, Zafereo ME, Ferlito. Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review. Adv. Ther 40(9):3681-3696, 2023. e-Pub 2023. PMID: 37436593.
Niu Z, Sun P, Liu H, Wei P, Wu J, Huang Z, Gross ND, Shete S, Wei Q, Zafereo ME, Calin GA, Li G. Functional genetic variants in TGF-β1 and TGF-βR1 in microRNA binding sites predict outcomes in patients with HPV-positive oropharyngeal squamous cell carcinoma. Clin Cancer Res 29(16):3081-3091, 2023. e-Pub 2023. PMID: 37327315.
Sun P, Wei P, Liu H, Wu J, Gross ND, Sikora AG, Wei Q, Shete S, Zafereo ME, Liu J, Li G. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy. EBioMedicine 94:104722, 2023. e-Pub 2023. PMID: 37487414.
Wang JR, Zafereo ME, Wang W, Joshu C, Ray D. Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma. J Clin Endocrinol Metab. e-Pub 2023. PMID: 37453101.
Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau CK, Pan T, Yan Y, Tran TM, Li J, Kieser R, Zhao X, Wang J, Nurieva R, Williams MD, Cabanillas ME, Dadu R, Busaidy NL, Zafereo M, Navin N, Lai SY, Gao R. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest 133(11):None, 2023. PMID: 37053016.
Lu L, Wang JR, Henderson YC, Bai S Yang J, Hu M, Shiau CK, Pan TY, Yan Y, Tran TM, Li J, Kieser R, Zhao X, Wang J, r N, Williams MD, Cabanillas ME, Dadu R, Busaidy N, Zafereo ME, Navin N, Lai SY, Gao R. Anaplastic Transformation in thyroid cancer revealed by single cell transcriptomics. J Clin Invest 133(11), 2023. e-Pub 2023. PMID: None.
Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann MC, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo ME. Surgery after BRAF-Directed Therapy is Associated wtih Improved Survival in BRAF V600E Mutant Anaplstic Thyroid Cancer. Thyroid 33(4):484-491, 2023. e-Pub 2023. PMID: 36762947.
Contrera KJ, Tam S, Pytynia K, Diaz EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, Pisters PWT, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol 30(4):2331-2338, 2023. e-Pub 2022. PMID: 36581726.
Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NL. Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head Neck 45(3):547-554, 2023. PMID: 36524701.
Chen YH, Cabanillas M, Sperling J, Xu L, Goswami M, Maniakas A, Williams MD, Lai SY, Busaidy N, Dadu R, Zafereo ME, Wang JR. Prior thyroid and non-thyroid cancer history do not significantly alter overall survival in patients diagnosed with anaplastic thyroid carcinoma. Thyroid 33(3):321-329, 2023. e-Pub 2023. PMID: 36511380.
Sehnem L, Noureldine SI, Avci S, Isiktas G, Elshamy M, Saito Y, Ahmed AHA, Tierney HT, Trinh LN, Karcioglu AS, Cheung AY, Otremba M, Krishnamurthy V, Heiden K, Jin J, Shin J, Siperstein A, Zafereo ME, Tufano RP, Randolph GW, Kebebew E, Milas M, Duh QY, Berber E. A multicenter evaluation of near-infrared autofluorescence imaging of parathyroid glands in thyroid and parathyroid surgery. Surgery 173(1):132-137, 2023. e-Pub 2022. PMID: 36511281.
Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 33(1):129-132, 2023. e-Pub 2022. PMID: 36503246.
Martinez J, Zafereo ME. Parathyroid Autofluorescence During Thyroid Surgery: Utility and Limitations. Video Endocrinology:86 - 87. e-Pub 2022. PMID: None.
Fitzgerald CWR, Davies JC, de Almeida JR, Rich JT, Orsini M, Eskander A, Monteiro E, Mimica X, Mclean T, Cracchiolo JR, Ganly I, Hessel A, Tam S, Wei D, Goepfert R, Su J, Xu W, Zafereo ME, Goldstein DP, Cohen MA. Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study. Oral Oncol 134:106089, 2022. e-Pub 2022. PMID: 36057225.
Contrera KJ, Zafereo ME, Yaniv D, Roberts DB, Gillenwater AM, Hanna EY, Weber RS, Myers JN, Chang EI, Garvey PB, Hanasono MM, Yu P, Hutcheson KA, Fuller CD, Tyler MA, Neskey DM. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol 134(None):106127, 2022. e-Pub 2022. PMID: 36155359.
Sajisevi M, Caulley L, Eskandr A, Du YJ, Auh E, Karabachev A, Callas P, Conradie W, Martin L, Pasternak J, Golbon B, Rolighed L, Abdelhamid Ahmed AH, Badhey A, Cheung AY, Corsten M, Forner D, Liu JC, Mavedatnia D, Meltzer C, Noel JE, Patel V, Sharma A, Tang AL, Tsao G, Venkatramani M, Williams M, Wrenn SM, Zafereo ME, Stack BC, Randolph GW, Davies L. Evaluating the Rising Incidence of Thyroid Cancer and Thyroid Nodule Detection Modes: A Multinational, Multi-institutional Analysis. JAMA Otolaryngol Head Neck Surg 148(9):811-818, 2022. PMID: 35834240.
Contrera KJ, Huang AT, Shenson JA, Tang C, Roberts D, Myers JN, Weber RS, Lai SY, Williams M, El-Hallal M, Jacob D, Zafereo ME. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma. Surgical Oncology 44(101804):101804, 2022. e-Pub 2022. PMID: 35932620.
Wang JR, Montierth M, Xu L, Goswami M, Zhao X, Cote G, Wang W, Iyer P, Dadu R, Busaidy NL, Lai SY, Gross ND, Ferrarotto R, Lu C, Gunn GB, Williams MD, Routbort M, Zafereo ME, Cabanillas ME. Impact of Somatic Mutations on Survival Outcomes in Patients with Anaplastic Thyroid Carcinoma. JCO Precis Oncol 6:e2100504, 2022. e-Pub 2022. PMID: 35977347.
Shonka DC, Ho A, Chintakuntlawar AV, Geiger JL, Park JC, Seetharamu N, Jasim S, Abdelhamid Ahmed AH, Bible KC, Brose MS, Cabanillas ME, Dabekaussen K, Davies L, Dias-Santagata D, Fagin JA, Faquin WC, Ghossein RA, Gopal RK, Miyauchi A, Nikiforov YE, Ringel MD, Robinson B, Ryder MM, Sherman EJ, Sadow PM, Shin JJ, Stack BC, Tuttle RM, Wirth LJ, Zafereo ME, Randolph GW. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment. Head Neck 44(6):1277-1300, 2022. e-Pub 2022. PMID: 35274388.
Contrera KJ, Chinn SB, Weber RS, Roberts D, Myers JN, Lai SY, Lewis CM, Hessel AC, Gillenwater AM, Mulcahy CF, Yu P, Hanasono MM, Fuller CD, Chambers MS, Zafereo ME. Outcomes after definitive surgery for mandibular osteoradionecrosis. Head Neck 44(6):1313-1323, 2022. e-Pub 2022. PMID: 35238096.
Waguespack SG, Tewari SO, Busaidy NL, Zafereo ME. Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?. JCO Precis Oncol e2100467(6):e2100467, 2022. e-Pub 2022. PMID: 35420905.
Caulley L, Eskander A, Yang W, Auh E, Cairncross L, Cho NL, Golbon B, Iyer S, Liu JC, Lee PJ, Lindeman B, Meltzer C, Molin N, Moore A, Noel J, Nozolino H, Pasternak J, Price B, Ramsay T, Rolighed L, Sajisevi M, Sharma A, Sinclair C, Sorensen M, Tae K, Tang AL, Tsao G, Williams M, Wrenn S, Xing MH, Zafereo ME, Stack BC, Randolph G, Davies L. Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms. JAMA Otolaryngol Head Neck Surg 148(2):99-106, 2022. e-Pub 2021. PMID: 34817546.
Vander Poorten V, Goedseels N, Triantafyllou A, Sanabria A, Clement PM, Cohen O, Golusinski P, Guntinas-Lichius O, Piazza C, Randolph GW, Rinaldo A, Ronen O, Cabanillas ME, Shaha AR, Teng Y, Tufano RP, Williams MD, Zafereo ME, Ferlito A. Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 13(None):971249, 2022. e-Pub 2022. PMID: 36204100.
Davies JC, Hugh S, Rich JT, de Almeida JR, Gullane PJ, Orsini M, Eskander A, Monteiro E, Mimica X, McGill M, Cohen MA, Cracchiolo JR, Teaima A, Tam S, Wei D, Goepfert R, Zafereo ME, Su J, Xu W, Goldstein DP. Association of Pharyngocutaneous Fistula With Cancer Outcomes in Patients After Laryngectomy: A Multicenter Collaborative Cohort Study. JAMA Otolaryngol Head Neck Surg 147(12):1027-1034, 2021. e-Pub 2021. PMID: 34323968.
Banik GL, Shindo ML, Kraimer KL, Manzione KL, Reddy A, Kazahaya K, Bauer AJ, Rastatter JC, Zafereo ME, Waguespack SG, Chelius DC, Quintanilla-Dieck L. Prevalence and Risk Factors for Multifocality in Pediatric Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 147(12):1100-1106, 2021. e-Pub 2021. PMID: 34734994.
Neurological Imaging EPO, Zander D, Bunch PM, Policeni B, Juliano AF, Carneiro-Pla D, Dubey P, Gule-Monroe MK, Hagiwara M, Hoang JK, Jain V, Kim LT, Moonis G, Parsons MS, Rath TJ, Solórzano CC, Subramaniam RM, Taheri MR, DuChene Thoma K, Trout AT, Zafereo ME, Corey AS. ACR Appropriateness Criteria® Parathyroid Adenoma. J Am Coll Radiol 18(11S):S406-S422, 2021. PMID: 34794597.
Coca-Pelaz A, Rodrigo JP, Shah JP, Sanabria A, Al Ghuzlan A, Silver CE, Shaha AR, Angelos P, Hartl DM, Mäkitie AA, Olsen KD, Owen RP, Randolph GW, Simó R, Tufano RP, Kowalski LP, Zafereo ME, Rinaldo A, Ferlito A. Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis. Adv Ther 38(10):5144-5164, 2021. e-Pub 2021. PMID: 34423400.
Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo ME, Johnson FM, Lai SY. Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity. J Clin Endocrinol Metab 106(11):e4652-e4665, 2021. e-Pub 2021. PMID: 34147031.
Henderson YC, Mohamed ASR, Maniakas A, Chen Y, Powell RT, Peng S, Cardenas M, Williams MD, Bell D, Zafereo ME, Wang RJ, Scherer SE, Wheeler DA, Cabanillas ME, Hofmann MC, Johnson FM, Stephan CC, Sandulache V, Lai SY. A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab 106(10):2962-2978, 2021. e-Pub 2021. PMID: 34120183.
Qin Y, Wang JR, Wang Y, Iyer P, Cote GJ, Busaidy NL, Dadu R, Zafereo ME, Williams MD, Ferrarotto R, Gunn GB, Wei P, Patel K, Hofmann MC, Cabanillas ME. Clinical Utility of Circulating Cell-free DNA Mutations in Anaplastic Thyroid Carcinoma. Thyroid 31(8):1235-1243, 2021. e-Pub 2021. PMID: 33599171.
Shojaie D, Hoffman AS, Amaku R, Cabanillas ME, Sosa JA, Waguespack SG, Zafereo ME, Hu MI, Grubbs EE. Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid. JMIR Form Res 3(7):e27484, 2021. e-Pub 2021. PMID: 34269691.
Hu MI, Waguespack SG, Dosiou C, Ladenson PW, Livhits MJ, Wirth LJ, Sadow PM, Krane JF, Stack BC, Zafereo ME, Ali SZ, Weitzman SP, Hao Y, Babiarz JE, Kennedy GC, Kloos RT. Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. J Clin Endocrinol Metab 106(8):2198-2207, 2021. e-Pub 2021. PMID: 34009369.
Luginbuhl A, Kahue CN, Stewart M, Curry JM, Weed D, Zender C, Netterville J, Zafereo ME. Head and neck surgery global outreach: Ethics, planning, and impact. Head Neck 43(6):1780-1787, 2021. e-Pub 2021. PMID: 33586258.
Nies M, Vassilopoulou-Sellin R, Bassett RL, Yedururi S, Zafereo ME, Cabanillas ME, Sherman SI, Links TP, Waguespack SG. Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape. J Clin Endocrinol Metab 106(4):e1683-e1697, 2021. e-Pub 2020. PMID: 33382403.
Piazza C, Lancini D, Tomasoni M, D'Cruz A, Hartl DM, Kowalski LP, Randolph GW, Rinaldo A, Shah JP, Shaha AR, Simo R, Vander Poorten V, Zafereo ME, Ferlito A. Tracheal and Cricotracheal Resection With End-to-End Anastomosis for Locally Advanced Thyroid Cancer: A Systematic Review of the Literature on 656 Patients. Front Endocrinol (Lausanne) 12(None):779999, 2021. e-Pub 2021. PMID: 34858348.
Boukovalas S, Goepfert RP, Smith JM, Mecham E, Liu J, Zafereo ME, Chang EI, Hessel AC, Hanasono MM, Gross ND, Yu P, Lewin JS, Lewis CM, Diaz EM, Weber RS, Myers JN, Offodile AC. Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center. Cancer 126(22):4905-4916, 2020. e-Pub 2020. PMID: 32931057.
Yang Z, Qi X, Gross N, Kou X, Bai Y, Feng Y, Wang B, Zafereo ME, Li G, Sun C, Li H, Chen X, Huang Z. The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A. J Cell Mol Med 24(22):13163-13170, 2020. e-Pub 2020. PMID: 32989896.
Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo ME. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol 6(9):1397-1404, 2020. e-Pub 2020. PMID: 32761153.
Cabanillas ME, Dadu R, Iyer P, Wanland KB, Busaidy NL, Ying A, Gule-Monroe M, Wang JR, Zafereo ME, Hofmann MC. Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors. Thyroid 30(9):1288-1296, 2020. e-Pub 2020. PMID: 32216548.
Zafereo ME, Yu J, Onakoya PA, Aswani J, Baidoo K, Bogale M, Cairncross L, Cordes S, Daniel A, Diom E, Maurice ME, Mohammed GM, Biadgelign MG, Koné FI, Itiere A, Koch W, Konney A, Kundiona I, Macharia C, Mashamba V, Moore MG, Mugabo RM, Noah P, Omutsani M, Orloff LA, Otiti J, Randolph GW, Sebelik M, Todsen T, Twier K, Fagan JJ. African Head and Neck Society Clinical Practice guidelines for thyroid nodules and cancer in developing countries and limited resource settings. Head Neck 42(8):1746-1756, 2020. e-Pub 2020. PMID: 32144948.
Zafereo ME, McIver B, Vargas-Salas S, Domínguez JM, Steward DL, Holsinger FC, Kandil E, Williams M, Cruz F, Loyola S, Solar A, Roa JC, León A, Droppelman N, Lobos M, Arias T, Kong CS, Busaidy N, Grubbs EG, Graham P, Stewart J, Tang A, Wang J, Orloff L, Henríquez M, Lagos M, Osorio M, Schachter D, Franco C, Medina F, Wohllk N, Diaz RE, Veliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Traipe E, Marín L, Miranda G, Bruce E, Bracamonte M, Mena N, González HE. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two-Independent Multicenter, Prospective Validation Trials. Thyroid 30(5):704-712, 2020. e-Pub 2020. PMID: 31910118.
Debnam JM, Guha-Thakurta N, Sun J, Wei W, Zafereo ME, Cabanillas ME, Buisson NM, Schellingerhout D. Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT. AJNR Am J Neuroradiol 41(5):844-851, 2020. e-Pub 2020. PMID: 32327435.
Wu SY, Chiang YJ, Fisher SB, Sturgis EM, Zafereo ME, Nguyen S, Grubbs EG, Graham PH, Lee JE, Waguespack SG, Perrier ND. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center. World J Surg 44(2):442-451, 2020. e-Pub 2019. PMID: 31686157.
Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo ME, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope 130(1):146-153, 2020. e-Pub 2019. PMID: 30756394.
Gan Q, Edeiken BS, Chen MM, Grubbs EG, Busaidy NL, Zafereo ME, Perrier ND, Gule-Monroe MD, Krishnamurthy S. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center. J Am Soc Cytopathol 8(6):309-316, 2019. e-Pub 2019. PMID: 31526696.
Debnam JM, Vu T, Sun J, Wei W, Krishnamurthy S, Zafereo ME, Weitzman SP, Garg N, Ahmed S. Vascular flow on doppler sonography may not be a valid characteristic to distinguish colloid nodules from papillary thyroid carcinoma even when accounting for nodular size. Gland Surg 8(5):461-468, 2019. PMID: 31741876.
Tran J, Zafereo ME. Segmental tracheal resection (nine rings) and reconstruction for carcinoma showing thymus-like differentiation (CASTLE) of the thyroid. Head Neck 41(9):3478-3481, 2019. e-Pub 2019. PMID: 31233256.
Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid 29(8):1036-1043, 2019. PMID: 31319771.
Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo ME, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol 145(8):1977-1986, 2019. e-Pub 2019. PMID: 31309300.
Zafereo ME, Yu J, Angelos P, Brumund K, Chuang HH, Goldenberg D, Lango M, Perrier N, Randolph G, Shindo ML, Singer M, Smith R, Stack BC, Steward D, Terris DJ, Vu T, Yao M, Tufano RP. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck 41(7):2398-2409, 2019. e-Pub 2019. PMID: 31002214.
Martínez JRW, Vargas-Salas S, Gamboa SU, Muñoz E, Domínguez JM, León A, Droppelmann N, Solar A, Zafereo ME, Holsinger FC, González HE. The Combination of RET, BRAF and Demographic Data Identifies Subsets of Patients with Aggressive Papillary Thyroid Cancer. Horm Cancer 10(2-3):97-106, 2019. e-Pub 2019. PMID: 30903583.
Amit M, Tam S, Takahashi H, Choi KY, Zafereo ME, Bell D, Weber RS. Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer. Head Neck 41(5):1270-1276, 2019. e-Pub 2018. PMID: 30537405.
Cervenka B, Pipkorn P, Fagan J, Zafereo ME, Aswani J, Macharia C, Kundiona I, Mashamba V, Zender C, Moore M. Oral cavity cancer management guidelines for low-resource regions. None 41(3):799-812, 2019. e-Pub 2019. PMID: 30666743.
Ting J, Bell D, Ahmed S, Ying A, Waguespack SG, Tu SM, Weber R, Zafereo ME. Primary Malignant Thyroid Teratoma: An Institutional Experience. Thyroid 29(2):229-236, 2019. PMID: 30759052.
Tam S, Amit M, Zafereo ME, Bell D, Weber RS. Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck 41(1):177-184, 2019. e-Pub 2018. PMID: 30537401.
Tran J, Zafereo ME. Parapharyngeal Dissection for Papillary Thyroid Cancer. VideoEndocrinology 6(1), 2019. e-Pub 2019. PMID: 32025530.
Iyer PC, Cote GJ, Hai T, Gule-Monroe M, Bui-Griffith J, Williams MD, Hess K, Hofmann MC, Dadu R, Zafereo ME, Busaidy NL, Ferrarotto R, Subbiah V, Gross N, Gunn BJ, Garden AS, Skinner HD, Cabanillas ME. Circulating BRAF V600E cell free DNA (cfDNA) as a biomarker in the management of Anaplastic Thyroid Carcinoma. JCO Precision Oncology 2:7-11, 2018. e-Pub 2018. PMID: None.
Jaber T, Waguespack SG, Cabanillas ME, Elbanan M, Vu T, Dadu R, Sherman SI, Amit M, Santos EB, Zafereo ME, Busaidy NL. Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. J Clin Endocrinol Metab 103(10):3698-3705, 2018. e-Pub 2018. PMID: 30032208.
Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions. Thyroid 28(10):1301-1310, 2018. e-Pub 2018. PMID: 30141373.
Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, Goretzki PE, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC, Tolley NS, Slycke SV, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo ME, Randolph GW. International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data. Laryngoscope 128 Suppl 3(None):S18-S27, 2018. e-Pub 2018. PMID: 30291765.
Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, Goretzki PE, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo ME, Dralle H. International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal. Laryngoscope 128 Suppl 3(None):S1-S17, 2018. e-Pub 2018. PMID: 30289983.
Working Group MLC, Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A, Vock D, Weber RS, Lai SY, Gunn GB, Zafereo ME, Morrison WH, Ferrarotto R, Garden AS, Rosenthal DI, Fuller CD. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck 40(9):2060-2069, 2018. e-Pub 2018. PMID: 29756307.
Tam S, Amit M, Boonsripitayanon M, Busaidy NL, Cabanillas ME, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis EM, Zafereo ME. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid 28(8):982-990, 2018. e-Pub 2018. PMID: 29936892.
Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo ME, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD. A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?. Clin Transl Radiat Oncol 12:40-46, 2018. e-Pub 2018. PMID: 30148217.
Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo ME, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas ME. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer 6(1):68, 2018. e-Pub 2018. PMID: 29996921.
Cabanillas ME, Ferrarotto R, Garden AS, Ahmed S, Busaidy NL, Dadu R, Williams MD, Skinner H, Gunn GB, Grosu H, Iyer P, Hofmann MC, Zafereo ME. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid 28(7):945-951, 2018. e-Pub 2018. PMID: 29742974.
Sakafu LL, Mselle TF, Mwaiselage JD, Maunda KK, Eddin BS, Zafereo ME. Thyroid Cancer and Iodine Deficiency Status: A 10-Year Review at a Single Cancer Center in Tanzania. OTO Open 2(2):2473974X18777238, 2018. e-Pub 2018. PMID: 30480218.
Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol 79:1-8, 2018. e-Pub 2018. PMID: 29598944.
Fundakowski CE, Hales NW, Agrawal N, Barczynski M, Camacho PM, Hartl DM, Kandil E, Liddy WE, McKenzie TJ, Morris JC, Ridge JA, Schneider R, Serpell J, Sinclair CF, Snyder SK, Terris DJ, Tuttle RM, Wu CW, Wong RJ, Zafereo ME, Randolph GW. Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck 40(4):663-675, 2018. e-Pub 2018. PMID: 29461666.
Ahmed S, Ghazarian MP, Cabanillas ME, Zafereo ME, Williams MD, Vu T, Schomer DF, Debnam JM. Imaging of Anaplastic Thyroid Carcinoma. AJNR Am J Neuroradiol 39(3):547-551, 2018. e-Pub 2017. PMID: 29242360.
Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Association of Lymph Node Density With Survival of Patients with Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 144(2):108-114, 2018. PMID: 29192312.
Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo ME, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid 28(1):79-87, 2018. e-Pub 2017. PMID: 29161986.
Pena I, Clayman GL, Grubbs EG, Bergeron JM, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME. Management of the Lateral Neck Compartment in Patients with Sporadic Medullary Thyroid Cancer. Head Neck 40(1):79-85, 2018. e-Pub 2017. PMID: 29044788.
Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Gunn GB, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 143(12):1244-1251, 2017. PMID: 29098272.
Christakis I, Silva AM, Williams MD, Garden A, Grubbs EG, Busaidy NL, Lee JE, Perrier ND, Zafereo ME. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol 7(6):e463-e470, 2017. e-Pub 2017. PMID: 28751227.
Liu B, Mitani Y, Rao X, Zafereo ME, Zhang J, Zhang J, Futreal PA, Lozano G, El-Naggar AK. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma. J Natl Cancer Inst 109(10), 2017. PMID: 29117356.
Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck 39(10):2079-2087, 2017. e-Pub 2017. PMID: 28741749.
Chinn SB, Zafereo ME, Waguespack SG, Edeiken BS, Roberts DB, Clayman GL. Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer. Thyroid 27(10):1291-1299, 2017. e-Pub 2017. PMID: 28806882.
Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck 39(8):1609-1620, 2017. e-Pub 2017. PMID: 28464542.
Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, Thakar S, Thuro B, Prieto VG, Ross MI, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol 95(4):e323-e328, 2017. e-Pub 2016. PMID: 27775232.
Rao SN, Zafereo ME, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas ME. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid 27(5):672-681, 2017. e-Pub 2017. PMID: 28068873.
Goepfert RP, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC, Lewis CM, Weber RS, Gross ND. Complications, hospital length of stay, and readmission after total laryngectomy. Cancer 123(10):1760-1767, 2017. e-Pub 2016. PMID: 28026864.
Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS. Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy. Head Neck 39(4):633-638, 2017. e-Pub 2016. PMID: 28006086.
Sheu T, Vock DM, Mohamed AS, Gross N, Mulcahy C, Zafereo ME, Gunn GB, Garden AS, Sevak P, Phan J, Lewin JS, Frank SJ, Beadle BM, Morrison WH, Lai SY, Hutcheson K, Marai GE, Canahuate GM, Kies M, El-Naggar A, Weber RS, Rosenthal DI, Fuller CD. Conditional Survival Analysis of Patients with Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram. Sci Rep 9(7:43928), 2017. PMID: 28276466.
Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo ME, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
Gitomer SA, Hutcheson KA, Christianson BL, Samuelson MB, Barringer DA, Roberts DB, Hessel AC, Weber RS, Lewin JS, Zafereo ME. Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture. Head Neck 38(12):1765-1771, 2016. e-Pub 2016. PMID: 27394060.
Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 96(1):30-41, 2016. e-Pub 2016. PMID: 27325480.
Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 95(4):1117-31, 2016. e-Pub 2016. PMID: 27354127.
Zafereo ME, Xu L, Dahlstrom KR, Viamonte CA, El-Naggar AK, Wei Q, Li G, Sturgis EM. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol 56:47-53, 2016. e-Pub 2016. PMID: 27086486.
Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck 38 Suppl 1:E1962-8, 2016. e-Pub 2016. PMID: 26879395.
Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo ME, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK. Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res 22(3):725-33, 2016. e-Pub 2015. PMID: 26631609.
Cata JP, Zafereo ME, Villarreal J, Unruh BD, Truong A, Truong DT, Feng L, Gottumukkala V. Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. J Clin Anesth 27(8):672-9, 2015. e-Pub 2015. PMID: 26371714.
Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. Oral Oncol 51(2):195-201, 2015. e-Pub 2014. PMID: 25444304.
Zhang C, Sturgis EM, Zheng H, Zafereo ME, Wei Q, Li G. TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. Int J Cancer 135(7):1615-24, 2014. e-Pub 2014. PMID: 24550071.
Gan SJ, Dahlstrom KR, Peck BW, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593-601, 2013. e-Pub 2013. PMID: 23605777.
Peck BW, Dahlstrom KR, Gan SJ, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 35(6):794-9, 2013. e-Pub 2012. PMID: 22711172.
Rosenberg TL, Kelley K, Dowdall JR, Replogle WH, Liu JC, Raol NP, Zafereo ME. Section for residents and fellows-in-training survey results. Otolaryngol Head Neck Surg 148(4):582-8, 2013. e-Pub 2013. PMID: 23396591.
Xu L, Mugartegui L, Li G, Sarlis NJ, Wei Q, Zafereo ME, Sturgis EM. Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans. Mol Carcinog 51 Suppl 1:E 158-67, 2012. e-Pub 2012. PMID: 22415807.
Reitzel LR, Nguyen N, Zafereo ME, Li G, Wei Q, Sturgis EM. Neighborhood deprivation and clinical outcomes among head and neck cancer patients. Health Place 18(4):861-8, 2012. e-Pub 2012. PMID: 22445028.
Zhang Y, Sturgis EM, Huang Z, Zafereo ME, Wei Q, Li G. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer 118(2):485-92, 2012. e-Pub 2011. PMID: 21717430.
Zhang Y, Sturgis EM, Zafereo ME, Wei Q, Li G. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Cancer 117(6):1227-35, 2011. e-Pub 2010. PMID: 21381012.
Zafereo ME, Weber RS, Lewin JS, Roberts DB, Hanasono MM. Complications and functional outcomes following complex oropharyngeal reconstruction. Head Neck 32(8):1003-11, 2010. PMID: 19953614.
Lei D, Sturgis EM, Wang LE, Liu Z, Zafereo ME, Wei Q, Li G. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 19(6):1484-91, 2010. e-Pub 2010. PMID: 20501759.
Li F, Sturgis EM, Chen X, Zafereo ME, Wei Q, Li G. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer 116(10):2350-9, 2010. PMID: 20225330.
Lei D, Sturgis EM, Liu Z, Zafereo ME, Wei Q, Li G. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis 31(2):222-7, 2010. e-Pub 2009. PMID: 19955391.
Li F, Sturgis EM, Zafereo ME, Liu Z, Wang LE, Wei Q, Li G. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer 125(11):2660-5, 2009. PMID: 19585505.
Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB, Weber RS. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 115(24):5723-33, 2009. PMID: 19760612.
Chen LM, Li G, Reitzel LR, Pytynia KB, Zafereo ME, Wei Q, Sturgis EM. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila) 2(9):782-91, 2009. e-Pub 2009. PMID: 19737985.
Zafereo ME, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis 30(6):997-1002, 2009. e-Pub 2009. PMID: 19369580.
Zafereo ME, Sturgis EM, Aleem S, Chaung K, Wei Q, Li G. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila) 2(5):432-9, 2009. e-Pub 2009. PMID: 19401526.
Zafereo ME, Taylor RJ, Pereira KD. Supraglottoplasty for laryngomalacia with obstructive sleep apnea. Laryngoscope 118(10):1873-7, 2008. PMID: 18641529.
Zafereo ME, Fakhri S, Prayson R, Batra PS, Lee J, Lanza DC, Citardi MJ. Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 138(4):452-8, 2008. PMID: 18359353.
Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 30(1):75-84, 2008. PMID: 17694557.
Kaszuba SM, Zafereo ME, Rosenthal DI, El-Naggar AK, Weber RS. Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. Arch Otolaryngol Head Neck Surg 133(6):546-50, 2007. PMID: 17576904.

Invited Articles

Sarvestani AL, Lambdin J, Hu M, Cabanillas M, Waguespack SG, Hernandez JM, Zafereo ME. Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers. Ann Surg Oncol 31(4):2202-2203, 2024. e-Pub 2024. PMID: 38245643.
Boucai L, Zafereo ME, Cabanillas ME. Thyroid Cancer: A Review. JAMA 331(5):425-435, 2024. PMID: 38319329.
Nardo M, Gouda MA, Nelson BE, Barreto CMN, Slade JH, Poullard A, Zafereo ME, Hu MI, Cabanillas ME, Subbiah V. Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers. Cell Rep Medicine 12(101332), 2023. PMID: 38118420.
Hanba, C, Zafereo, M. Neoadjuvant therapy prior to surgery for advanced thyroid cancer. Current Opinion in Endocrine and Metabolic Research 32, 2023. PMID: None.
Contrera KJ, Tam S, Pytynia K, Diaz EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, Pisters PWT, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol 30(4):2341-2342, 2023. e-Pub 2023. PMID: 36720835.
Mete O, Asa SL, Baloch ZW, Erickson L, Ezzat S, Rotstein L, Sawka AM, Seethala RR, Zafereo ME. College of American Pathologists Protocol for the Examination of Specimens from Patients with Carcinomas of the Thyroid Gland. None, 2023. e-Pub 2022. PMID: None.
Hofmann MC, Kunnimalaiyaan M, Wang JR, Busaidy NL, Sherman SI, Lai SY, Zafereo ME, Cabanillas ME. Molecular Mechanisms of Resistance to Kinase Inhibitors in Thyroid Cancers. Endocr Relat Cancer 29(11):R173-R190, 2022. e-Pub 2022. PMID: 35975971.
Walgama E, Busaidy N, Zafereo M. Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer. Endocrinol Metab Clin North Am 51(2)(379-389):379-389, 2022. e-Pub 2022. PMID: 35662447.
Maniakas A, Zafereo ME, Cabanillas ME. Anaplastic Thyroid Cancer: New Horizons and Challenges. Endocrinology Metab Clin North AM 51(2)(391-401), 2022. e-Pub 2022. PMID: 35662448.
Vinh D, Zafereo ME. Surgical Considerations in Thyroid Cancer: What the Radiologist Needs to Know. Neuroimaging Clin N Am 31(3):327-335, 2021. PMID: 34243867.
Fullmer T, Cabanillas ME, Zafereo M. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer. Front Endocrinol (Lausanne) 12:720723, 2021. e-Pub 2021. PMID: 34335481.
Dadu R, Bagheri-Yarmand R, Ringel MD, Grubbs EG, Zafereo ME, Cote G, Gagel RF, Robinson BG, Shaw KR, Hu MI. The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr Relat Cancer 27(8):T27-T39, 2020. e-Pub 2020. PMID: 32580150.
Maniakas A, Davies L, Zafereo ME. Thyroid Disease Around the World. Otolaryngol Clin North Am 51(3):631-642, 2018. e-Pub 2018. PMID: 29548512.
Cabanillas ME, Zafereo ME, Williams MD, Ferrarotto R, Dadu R, Gross N, Gunn GB, Skinner H, Cote G, Grosu HB, Iyer P, Busaidy NL. Recent advances and emerging therapies in anaplastic thyroid carcinoma. F1000Res 7(7), 2018. e-Pub 2018. PMID: 31583077.
Cabanillas ME, Zafereo ME, Gunn GB, Ferrarotto R. Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy. J Oncol Pract 12(6):511-8, 2016. PMID: 27288464.
Zafereo ME. Surgical salvage of recurrent cancer of the head and neck. Curr Oncol Rep 16(5):386, 2014. PMID: 24623521.
Zafereo ME. Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs. Otolaryngol Clin North Am 46(4):599-613, 2013. e-Pub 2013. PMID: 23910472.

Manuals, Teaching Aids, Other Teaching Publications

. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Oral Bleeding Emergency Management. None, 2022.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Salivary Cancer. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Cutaneous Melanoma. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Oral Cavity Cancer. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Larynx/Hypopharynx Cancer. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Unknown Primary. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Larynx Cancer. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Nasopharynx Cancer. None, 2020.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Oropharynx Cancer. None, 2020.
. Multidisciplinary Larynx Cancer Working Group Conditional Survival Analysis. None, 2019.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Larynx Cancer. None, 2019.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Larynx/Hypopharynx Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Salivary Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online cancer treatment algorithms Thyroid Nodule Evaluation. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Oropharynx Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Unknown Primary. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Nasopharynx Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Larynx Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Oral Cavity Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Larynx/Hypopharynx Cancer. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online survivorship algorithms Cutaneous Melanoma. None, 2017.
. Key Leader Core Team, MDACC Head and Neck Surgery online cancer treatment algorithms Larynx Cancer. None, 2015.
. Key Leader Core Team, MDACC Head and Neck Surgery online cancer treatment algorithms Oral Cavity Cancer. None, 2015.
Zafereo ME. Submandibular Salivary Tumours and Cancers, Developing World Clinical Guidelines for Head and Neck Cancer. African Head and Neck Society.
Zafereo ME. Parotid Tumors and Cancers, Developing World Clinical Guidelines for Head and Neck Cancer. African Head and Neck Society.
Zafereo ME. Thyroid nodules, Cancers and Goiters, Developing World Clinical Guidelines for Head and Neck Cancer. African Head and Neck Society.
. Hypothyroidism after Head and Neck Radiation. None.

Abstracts

Abdelhamid Ahmed AH, Russell MD, Kyriazidis N, Silver Karcioglu A, Sherman EJ, Ho AL, Fagin JA, Wong RJ, Busaidy NL, Zafereo ME, Sadow P, Park JC, Wirth LJ, Randolph GW. A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer. Journal of Clinical Oncology(41:16), 2023. PMID: None.
Kyriazidis N, Russell MD, Abdelhamid Ahmed AH, Silver Karcioglu A, Sherman EJ, Ho AL, Fagin JA, Wong RJ, Busaidy NL, Zafereo ME, Sadow P, Park JC, Wirth LJ, Randolph GW. A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer. World Congress on Thyroid Cancer (WCTC) London, United Kingdom, 2023. PMID: None.
Gonzalez H, Zafereo ME, Vargas S, Stewart D, Holsinger C, Kandil E, all E. African Head and Neck Society (AfHNS) Clinical Practice Guidelines for Head and Neck Cancers. XVII Latin American Thyroid Society Congress, 2019. PMID: None.
Hu M, Cote G, Zafereo ME, Hai T, Busaidy N, Cabanillas ME, Dadu R, Gagel R, Grubbs EG, Habra M, Jimenez C, Subbiah V, Waguespack SG, Williams MD, Sherman S. Emergence of Resistance-Associated Mutations of RET V804M and KRAS in Medullary Thyroid Carcinoma (MTC) Patients Treated with Tyrosine Kinase Inhibitors (TKI) Cabozantinib and Vandetanib. 89th Annual Meeting of the American Thyroid Association, 2019. PMID: None.
Zafereo ME, Wang J. Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival. None, 2018. PMID: None.
Gan Q, Zafereo ME. Prevalence and Significance of Indeterminate Cytopathology Results from Ultrasound-Guided Fine Needle Aspiration of Thyroid in a Large Referral Cancer Center. None, 2018. PMID: None.
Zafereo ME, Williams M. Altered Metalloproteinases in Aggressive Hurthle Cell Carcinomas. None, 2017. PMID: None.
Iyer P, Ferraroto R, Gule-Monroe M, Busaidy N, Dadu R, Habra M, Williams M, Hoffmann M, Zafereo ME, Skinner H, Cabanillas M. Pembrolizumab added to Kinsase Inhibitor Therapy in Anaplastic Thyroid Carcinoma (ATC): A Single Cancer Center's Experience. None, 2017. PMID: None.
Zafereo ME, Iyer P. Circulating BRAFV600E cell-free DNA detected by droplet digital PCR (ddPCR) as a biomarker in the management of anaplastic thyroid carcinoma (ATC) patients. None, 2017. PMID: None.
Jaber, T, Denai M, Grubbs E, Trotter C, Zafereo ME, Cabanillas M, Dadu R, Cote G, Hu M. The Utility of the Calcitonin to Carcinoembryogenic Antigen Ratio in Prognostication of Medullary Thyroid Carcinoma. None, 2017. PMID: None.
Sheu T, Garden AS, Fuller CD, Gunn GB, Nguyen T, Beadle BM, Morrison WH, Sio TT, Takiar V, Zafereo ME, Rosenthal DI, Frank SJ, Phan J. Reirradiation Utilizing Proton Radiation Therapy May Improve Toxicity Free Survival in Patients With Small-Volume, Recurrent Head And Neck Cancer. Int J Radiat Oncol Biol Phys 96(2S):E331, 2016. PMID: 27674401.
Mohamed AS, Pham BH, Messer JA, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Garden AS, Weber RS, Rosenthal DI, Fuller CD. Identification of Anatomic Correlates of Failure in Patients With T4a Larynx Cancer. Int J Radiat Oncol Biol Phys 96(2S):E343, 2016. PMID: 27674433.
Mohamed AS, Pham BH, Messer JA, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Garden AS, Weber RS, Rosenthal DI, Fuller CD. Identification of Anatomic Correlates of Failure in Patients with t4a Larynx Cancer. None, 2016. PMID: None.
Mulcahy C, Mohamed AS, Weber R, Lai S, Fuller C, Rosenthal D, El-Naggar A, Hutcheson K, Gunn B, Garden A, Kies M, Lewin J, Morrison W, Zafereo ME. Comorbidity and Survival in Locally Advanced Laryngeal Cancer. None, 2016. PMID: None.
Fox DP, Kansara S, Roberts DB, Wilson P, Williams MD, Cabanillas ME, Clayman GL, Zafereo ME. Hurthle Cell Carcinoma: A 19-year Clinical Experience. None, 2016. PMID: None.
Sheu T, Rosenthal DI, Gunn BG, Garden AS, Phan J, Gross N, Frank SJ, Beadle BM, Morrison WH, Zafereo ME, Kies M, Mohamed ASR, Fuller CD. Nomogram for estimating the conditional survival of locally advanced laryngeal cancer patients after radiotherapy. None, 2015. PMID: None.
Alsarraf L, Kumar VA, Zafereo ME, Ahmed S, Ginsberg L. Laryngeal Amyloidosis: Unique Imaging Features. None, 2014. PMID: None.
Awan M, Zafereo ME, Lewis CM, Guha-Thakurta N, Debnam J, Gunn G, Phan J, David RI, Fuller CD. Interdisciplinary Variation in Segmentation of High-Risk Postoperative Tumor Volumes in the Head and Neck. None, 2013. PMID: None.

Book Chapters

Fagan JJ, Zafereo ME, Marcus K, Russell MD, Randolph G. African Head and Neck Society Clinical Practice Guidelines for Thyroid Nodules and Cancer in Developing Countries and Limited Resource Settings. In: Practical Management of Thyroid Cancer. 3. Springer, 19-27, 2024.
Wang TS, Grubbs EG, McGill JF, Solorzano CC, Sturgeon C, Zafereo ME. Thyroid. In: Operative Standards for Cancer Surgery:Thyroid, Gastric, Rectum, Esophagus, Melanoma. 1. Lippincott Williams & Wilkins, 2022.
Kansara S, Cabanillas M, Zafereo ME. Neoadjuvant Therapy for Anaplastic Thyroid Cancer. In: Innovations in Modern Endocrine Surgery. 1. Springer, 81-88, 2021.
Kansara A, Cabanillas M, Zafereo ME. Anaplastic Thyroid Cancer. In: Head & Neck Endocrine Surgery: A Comprehensive Textbook, Surgical, and Video Atlas. None. None, 2021.
Maniakas A, Chen A, Chiang F, Zafereo ME. Lateral Neck Dissection: Indications and Technique. In: Surgery of the Thyroid and Parathyroid Glands. 3rd. None, 2021.
Low G, Wong R, Zafereo ME. Intraoperative Cranial Nerve Monitoring in Otolaryngology-Head and Neck Surgery. In: Recurrent Laryngeal Nerve Monitoring and Decision-Making in Advanced Thyroid Cancer. None. None, 2021.
Vinh, D, Bell D, Zafereo ME. Thyroid Neoplasms. In: Bailey’s Head and Neck Surgery Otolaryngology. 6th. Lippincott Williams & Wilkins, 2414-2422, 2021.
Ahmad F, Zafereo ME, Lai S. Management of Thyroid Neoplasms. In: Cummings Otolaryngology Head and Neck Surgery. 7th. None, 2021.
Ahmad F, Zafereo ME. Thyroid Cancer. In: Conn's Current Therapy 2020. 72nd. Elsevier, 2020.
Lee M, Waguespack SG, Graham PH, Hu MI, Zafereo ME. Syndromic Medullary Thyroid Carcinoma: MEN 2A and MEN 2B. In: Surgical and Medical Management of Diseases of the Thyroid and Parathyroid. 1st. Plural Publishing, Inc, 371-390, 2020.
Zafereo ME. Oncologic Components of Lymphadenectomy. In: Operative Standards for Cancer Surgery: Volume 2: Esophagus, Melanoma, Rectum, Stomach, Thyroid. None. Lippincott Williams & Wilkins, 2019.
Lim M, Zafereo ME. Salvage Neck Dissection: Indications, Workup, and Technical Considerations. In: Neck Dissection. None. Thieme, 2019.
George JR, Mongkol B, Zafereo ME. Neck Mass and Hoarseness (Papillary Thyroid Cancer). In: Case Studies in Otolaryngology- Head & Neck Surgery and Audiology. None. Anadem Publishing, 559 - 565, 2019.
Mays A, Zafereo ME. Medullary Thyroid Carcinoma Office-Based Scenario. In: Case Studies in Otolaryngology- Head & Neck Surgery and Audiology. None. Anadem Publishing, 566 - 569, 2019.
Zafereo ME, Weber RS. Thyroid Cancer. In: Conn's Current Therapy 2018. 70th. Elsevier, 2019.
Ahmad F, Zafereo ME. Thyroid Cancer. In: Conns Current Therapy 2019. 71st. Elsevier, 2019.
Tan M, Zafereo ME. Neck Mass. In: Case Studies in Otolaryngology- Head & Neck Surgery and Audiology. None. Anadem Publishing, 574, 2019.
Zafereo ME. Thyroid. In: Operative Standards for Cancer Surgery: Volume 2: Esophagus, Melanoma, Rectum, Stomach, Thyroid. None. Lippincott Williams & Wilkins, 2019.
Goepfert RP, Zafereo ME. Cancers of the Head and Neck. In: The MD Anderson Surgical Oncology Handbook. 4th. Lippincott Williams & Wilkins, 2017.
Lim MY, Zafereo ME, Grubbs E. Locally advanced differentiated thyroid cancer. In: Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide. 1st. Springer International, 379 - 417, 2016.
Zafereo ME, Weber RS. Thyroid Cancer. In: Conn's Current Therapy 2017. 69th edition. Elsevier, 2016.
Zafereo ME, Beadle B, Weber RS. Carcinoma of Oropharynx. In: Head and Neck Cancer Recurrence: Evidence-based Multidisciplinary Management. 8. Thieme Group, 2012.
Holsinger FC, Zafereo ME, Chung WY. Robotic Thyroidectomy: Surgical Technique for Lobectomy Via Axillary Incision without Carbon Dioxide Insufflation. In: Cohen & Clayman: Atlas of Head and Neck Surgery. 1. Elsevier Saunders, 480 - 499, 2011.

Books (edited and written)

Otolaryngology- Head CSI, Surgery N, Preparatory Review AA. Otolaryngology-Head and Neck Surgery: Clinical Case Studies. Ed(s) None. Thieme, 2019.

Less

Selected Presentations & Talks

Local Presentations

2024. Repeat neck surgeries: What to expect. Panelist. 27th International Thyroid Cancer Survivors’ Conference. Houston, Texas, US.
2024. Update in medullary thyroid cancer clinical trials. Invited. 27th International Thyroid Cancer Survivors’ Conference. Houston, Texas, US.
2024. Medullary thyroid cancer: Considerations before, during, and after surgery. Invited. 27th International Thyroid Cancer Survivors’ Conference. Houston, Texas, US.
2023. Multidisciplinary Management of Differentiated Thyroid Cancer. Conference. Baylor College of Medicine Resident Didactic Conference Series. Houston, TX, US.
2022. Rare Cancers at MD Anderson: The Anaplastic Thyroid Cancer Journey. Conference. MD Anderson Cancer Center Making Cancer History - Virtual Seminar. Houston, TX, US.
2020. Collaborative efforts with Head & Surgeons in Africa. Conference. 8th Annual Houston Global Health Collaborative Global Health Conference. Houston, TX, US.
2020. Endocrine Multidisciplinary Care Discussion Panel. Conference. MD Anderson Cancer Center - Cancer Network Integration Head & Neck/Endocrine Retreat. Houston, TX, US.
2020. Anaplastic Thyroid Cancer: Integration of Systemic Therapy with Surgery. Conference. MD Anderson Cancer Center - Cancer Network Integration Head & Neck/Endocrine Retreat. Houston, TX, US.
2019. Current Concepts in Head and Neck Cancer Surgery | Stump the Faculty Panel Discussion. Conference. MD Anderson Cancer Center. Houston, TX, US.
2019. Current treatment paradigms for advanced thyroid cancer: the evolving role of XRT in the era of targeted and immunotherapy. Conference. MDACC Department of Radiation Oncology - Lecture Series. Houston, TX, US.
2018. Surgery for Thyroid Cancer: From PTC to MTC. Conference. MD Anderson Cancer, Endocrine Neoplasia and HD. Houston, TX, US.
2018. Anaplastic Thyroid Cancer: Renewed Hope in the Age of Targeted Therapy. Conference. MDACC Development Office Faculty Presentation Series. Houston, TX, US.
2018. Locoregionally Advanced, Invasive, and Recurrent Thyroid Cancer. Conference. MD Anderson Cancer Center. Houston, TX, US.
2017. Comprehensive management of parotid neoplasms. Conference. Methodist Institute of Technology, Innovation, & Education. Houston, TX, US.
2017. TNM Staging and Diagnostic Evaluation of the Head and Neck Cancer Patient. Conference. Oral Oncology Symposium, MD Anderson Cancer Center. Houston, TX, US.
2017. Collaborative Global Efforts in Head & Neck Surgery. In: Global Education and Training Panel. Conference. Global Oncology Symposium: Cancer Care in Resource Challenged Environments, MD Anderson Cancer Center. Houston, TX, US.
2017. Surgery for Differentiated Thyroid Cancer: Lateral Neck and Retropharyngeal. Conference. 7th Current Concepts in the Management of Thyroid and Parathyroid Neoplasms, MD Anderson Cancer Center. Houston, TX, US.
2017. Evaluation and Management of Medullary Thyroid Cancer, Panel Discussion. Conference. 7th Current Concepts in the Management of Thyroid and Parathyroid Neoplasm, MD Anderson Cancer Center. Houston, TX, US.
2016. Surgical and Adjuvant Therapy Considerations with Medullary Thyroid. Conference. MD Anderson Cancer Center. Houston, TX, US.
2016. Management Dilemmas in Lateral Neck for Thyroid Cancer. Conference. Methodist Institute of Technology Innovation and Education (MITIE). Houston, TX, US.
2016. The Role of Surgery and Adjuvant Radiation Therapy for Invasive Medullary Thyroid Carcinoma. Conference. MD Anderson Cancer Center. Houston, TX, US.
2015. Hypercalcemia and Parathyroid Neoplasia Expert Panel Discussion. Conference. MD Anderson Cancer Center. Houston, TX, US.
2015. Differentiated Thyroid Carcinoma Expert Panel Discussion. Conference. MD Anderson Cancer Center. Houston, TX, US.
2014. Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Conference. Baylor College of Medicine Department of Medical Oncology. Houston, TX, US.
2014. Diagnostic Evaluation and Staging of the Oral Cavity and Oropharynx Cancer Patient. Conference. MD Anderson Cancer Center. Houston, TX, US.
2014. Value Based Healthcare in Head and Neck Cancer: Extending Quality and Value-Based Care to the Region. Conference. MD Anderson Cancer Center. Houston, TX, US.
2013. Recurrent squamous cell carcinoma of the Oropharynx. Conference. Baylor College of Medicine. Houston, TX, US.
2011. Human Papillomavirus in Squamous Cell Carcinoma of the Oropharynx. Conference. Academy of Family Physicians Primary Care Summit. Houston, TX, US.
2010. FAS and FASL genetic variants as predictors of survival and risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Conference. Baylor College of Medicine Research Symposium. Houston, TX, US.
2010. The Role of Salvage Surgery in Recurrent Oropharyngeal Squamous Cell Carcinoma. Conference. Houston Otolaryngologic Society Annual Meeting. Houston, TX, US.
2009. The Role of Salvage Surgery in Recurrent Oropharyngeal Squamous Cell Carcinoma. Conference. Baylor College of Medicine Research Symposium. Houston, TX, US.
2009. Oral Cavity Cancer in Young Patients: Evidence of an Association with HPV16. Conference. Houston Otolaryngologic Society Annual Meeting. Podium presentation. Houston, TX, US.
2009. Oral Cavity Cancer in Young Patients: Evidence of an Association with HPV16. Conference. Houston Surgical Society Annual Meeting. Houston, TX, US.
2008. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Conference. Baylor College of Medicine Research Symposium. Houston, TX, US.
2008. Oral Cavity Cancer in Young Patients: Evidence of an Association with HPV16. Conference. Baylor College of Medicine Research Symposium. Houston, TX, US.
2008. Supraglottoplasty for Laryngomalacia with Obstructive Sleep Apnea. Conference. Houston Society of Otolaryngology – Head and Neck Surgery Annual Meeting. Houston, TX, US.

Regional Presentations

2021. Targeted Strategies for Anaplastic Thyroid Cancer. Conference. MD Anderson Cancer Network Speaker's Bureau. Virtual Presentation, US.
2017. Management of the Involved Recurrent Laryngeal Nerve in Differentiated Thyroid Cancer: An Outcome Analysis. Conference. 71st Annual Meeting of the Canadian Society of Otolaryngology – Head and Neck Surgery, US.
2017. The Effect of Tumor Size in Patients with Minimal Extrathyroidal Extension in Differentiated Thyroid Cancer. Conference. American Head and Neck Society Combined Otolaryngology Spring Meeting. San Diego, CA, US.
2017. Lymph Node Density is a Predictor of Outcome in Differentiated Thyroid Cancer. Conference. American Head and Neck Society Combined Otolaryngology Spring Meeting. San Diego, CA, US.
2017. The role of adjuvant external beam radiotherapy in locally advanced differentiated thyroid cancer. Conference. American Head and Neck Society Combined Otolaryngology Spring Meeting. San Diego, CA, US.
2016. Oropharyngeal Cancer: Treatment Debate. Conference. Texas Association of Otolaryngology Annual Meeting. Dallas, TX, US.
2013. Head and Neck Melanoma. Conference. Christus St. John Hospital Grand Rounds. Nassau Bay, TX, US.
2013. Reducing Cancer Risk: Head and Neck Cancer and Beyond. Conference. Fluor Global Engineering Construction Company. Sugar Land, TX, US.
2013. Head and Neck Melanoma. Conference. Midland Memorial Hospital Grand Rounds. Midland, TX, US.
2012. High burden of Late Effects Upon entry into Head & Neck Survivorship Care. Conference. Cancer Prevention & Research Institute of Texas (CPRIT). Austin, TX, US.
2009. The Role of Salvage Surgery in Recurrent Oropharyngeal Squamous Cell Carcinoma. Conference. Texas Medical Association Spring Meeting and Texas Association of Otolaryngology Annual Meeting. Austin, TX, US.

National Presentations

2024. BRAF-altered ATC Treatment. Invited. Surgery of the Thyroid and Parathyroid Glands. Boston, MA, US.
2024. Neoadjuvant therapy for Medullary thyroid cancer. Invited. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
2024. How to Survive (or Even Thrive) Peer Review. Invited. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
2024. Advanced Thyroid Cancer: Updates on Therapeutic Options. Panelist. American Academy of Otolaryngology–Head and Neck Surgery Annual Meeting. Miami, FL, US.
2024. Integration of Targeted Therapy and Surgery in Advanced Thyroid Cancer Clinical Trials. Invited. American Head and Neck Society (AHNS) & Combined Otolaryngology Spring Meeting (COSM). Chicago, IL, US.
2024. Thyroid Cancer Round Table 2024 - From Microcarcinoma to advanced Management. Invited. American Society for Radiation Oncology (ASTRO). Phoenix, AZ, US.
2024. hyroid Cancer Round Table: From Microcarcinoma to Advanced Management. Invited. Multidisciplinary Head and Neck Cancer Symposium 2024. Phoenix, AZ, US.
2023. Novel Treatment Strategies for Advanced Thyroid Cancer. Invited. Arkansas State Society of Otolaryngology. Little Rock, AR, US.
2023. Strategies to Reduce Thyroid Cancer Locoregional Recurrence. Invited. Arkansas State Society of Otolaryngology. Little Rock, AR, US.
2023. Medullary Thyroid Cancer in 2023: Considerations before, during and after surgery. Invited. ThyCa: Thyroid Cancer Survivors; Association, Inc. Denver, CO, US.
2023. Advanced Thyroid Cancer: State of the Art Management. Invited. American Academy of Otolaryngology. Nashville, TN, US.
2023. Advanced Thyroid Cancer: Molecular Testing and Therapeutic Options. Invited. American Academy of Otolaryngology. Nashville, TN, US.
2023. Surgical Symposium: Value and Challenge of Multidisciplinary Team Approach: Controversies in Thyroidology. Invited. American Thyroid Association Annual Meeting. Washington, DC, US.
2023. Clinical Cases: Thyroid Tumors. Invited. Next Frontiers To Cure Cancer 2023. Virtual Presentation, US.
2023. Current Treatment of anaplastic thyroid carcinomas and tthe importance of multidisciplinary management. Invited. Next Frontiers To Cure Cancer 2023. Virtual Presentation, US.
2023. Evidence-based Thyroid Cancer Case Discussion. Invited. LSU Shreveport 3rd Annual Thyroid Conference. Hybrid Virtual, US.
2023. The Integration of Targeted Therapy and Surgery in Advanced Thyroid Cancer Clinical Trials. Invited. LSU Shreveport 3rd Annual Thyroid Conference. Hybrid Virtual, US.
2023. Towards a BRAF-mutated Anaplastic Thyroid Cancer Cooperative Group Clinical Trial. Invited. NCI Head and Neck Rare Tumors Task Force, US.
2023. Collaboration with Global Partners in Otolaryngology-Head & Neck Surgery-Global Health Symposium Roundtable. Invited. Rush University Otolaryngolgy-Head & Neck Surgery Global Health Symposium, US.
2023. Comparative Effectiveness of Subsequent Treatment After Partial Thyroidectomy for Follicular Thyroid Carcinoma: Panel Discussion. Invited. THANC (Thyroid, Head and Neck Cancer) Foundation. Virtual Panel, US.
2023. Invasive Thyroid Cancer Tumor Board - VIRTUAL. Invited. THANC (Thyroid, Head and Neck Cancer) Foundation. New York, NY, US.
2022. Novel Treatment Strategies for Locoregionally Advanced Thyroid Cancer. Invited. Lurie Cancer Center Multidisciplinary Symposium 2022. Chicago, IL, US.
2022. Surgery in the Era of Targeted Therapy for Anaplastic Thyroid Cancer. Invited. Harvard Medical School Annual Surgery of the Thyroid & Parathyroid Glands Course. Virtual Presentation, US.
2022. Novel Treatment strategies and therapeutics for advanced thyroid cancer. Invited. Taiwan Head & Neck Society 2022 Annual Meeting. Hybrid Meeting w/ Virtual Lecture, US.
2022. Anaplastic Thyroid Cancer Case Discussion and Panel. Invited. New York Head and Neck Society - 2022 Fall Scientific Meeting. New York, NY, US.
2022. The Role of Surgery in the new era of targeted therapies for anaplastic thyroid cancer. Invited. New York Head and Neck Society - 2022 Fall Scientific Meeting. New York, NY, US.
2022. Medullary Thyroid Cancer: Reconsideration of Iocoregional therapy in the era of RET kinase inhibitors. Invited. Thyroid Cancer Survivors Association Annual Meeting. Virtual Presentation, US.
2022. Advanced Thyroid Cancer: State of the Art Management: Panel Discussion. Invited. American Academy of Otolaryngology Annual Meeting 2022. Pittsburgh, PA, US.
2022. Advanced thyroid cancer: Integration of systemic targeted therapy with surgery. Invited. American Academy of Otolaryngology Annual Meeting 2022. Pittsburgh, PA, US.
2022. Advanced and Aggressive Thyroid Cancer - Evolving Diagnostics and Therapeutic Options: Panel Discussion. Invited. American Academy of Otolaryngology Annual Meeting 2022. Pittsburgh, PA, US.
2022. Advanced thyroid cancer: Tumorigenesis, mutations, and targets. Invited. American Academy of Otolaryngology Annual Meeting 2022. Pittsburgh, PA, US.
2022. Locally Advanced Thyroid Cancer: Intraoperative Strategies and Decision-Making. Invited. American Head and Neck Society. Virtual Presentation, US.
2022. Contemporary Anaplastic Thyroid Cancer Treatment Strategies, AHNS Reisdent/Fellow Course, Combined Otolaryngology Spring Meeting. Invited. American Head and Neck Society (AHNS). Dallas, TX, US.
2022. State of the Art: Anaplastic Thyroid Cancer, Rare Cancers Update Conference. Invited. HMP (Healthcare Made Practical) Education/HMP Global. VIRTUAL, US.
2022. Thyroid Cancer Panel and Case Discussion - Rare Cancers Update Conference. Invited. HMP (Healthcare Made Practical) Education/HMP Global. VIRTUAL, US.
2022. Multimodality Therapy for Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery. Invited. American Society for Radiation Oncology (ASTRO) Multidisciplinary Head & Neck Cancers Symposium 2022. Phoenix, AZ, US.
2022. Thyroid Cancer Case Presentation and Panel Discussion. Invited. Advances in Otolaryngology (89th Midwinter Conference of the Research Study Club of Los Angeles). Los Angeles, CA, US.
2022. Targeted Therapy and Immunotherapy for Thyroid. Invited. Advances in Otolaryngology (89th Midwinter Conference of the Research Study Club of Los Angeles). Los Angeles, CA, US.
2022. Surgical Considerations in Thyroid Cancer 2022. Invited. Advances in Otolaryngology (89th Midwinter Conference of the Research Study Club of Los Angeles). Los Angeles, CA, US.
2021. Anaplastic Thyroid Cancer: Surgeon's Perspective 2021. Invited. University of California San Diego Multidisciplinary Grand Rounds. Virtual Presentation, US.
2021. Thyroid: Good, Bad, Ugly. Invited. American Head and Neck Society. Virtual Webinar, US.
2021. Medullary Thyroid Cancer: Reconsideration of Iocoregional therapy in the era of RET kinase inhibitors. Invited. Thyroid Cancer Survivors Association Annual Meeting. Virtual Presentation, US.
2021. Thyroid Cancer Case Presentation and Discussion Roundtable. Invited. XXVIII Congresso De La Associacion Argentina De Cirugia De Cabeza Y Cuello (AACC). Virtual Presentation, US.
2021. Staging and Surgery for Differentiated Thyroid Cancer in 2021. Invited. XXVIII Congresso De La Associacion Argentina De Cirugia De Cabeza Y Cuello (AACC). Virtual Presentation, US.
2021. Advanced Thyroid Cancer: Molecular Testing and Therapeutic Options. Invited. American Academy of Otolaryngology-Head & Neck Surgery Annual Meeting 2021. Virtual Presentation, US.
2021. Operative Standards and Intraoperative Decision-Making: Thyroid Cancer. Invited. American College of Surgeons Virtual Clinical Congress 2021. Virtual Presentation, US.
2021. Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery. Invited. UT Health San Antonio Department of Hematology-Oncology. Virtual Presentation, US.
2021. Differentiated Thyroid Cancer Symposium Roundtable. Invited. XXVIII Brazilian Congress of Head and Neck Surgery. Virtual Presentation, US.
2021. Central compartment recurrence: diagnosis and surgical strategy. Invited. XXVIII Brazilian Congress of Head and Neck Surgery. Virtual Presentation, US.
2021. Medullary Thyroid Cancer Tumor Board. Invited. American Head & Neck Society and British Association of Endocrine and Thyroid Surgeons Symposium. Virtual presentation, US.
2021. HPV-Related Oropharyngeal Cancer Roundtable. Invited. American Academy of Otolaryngology - Head and Neck Surgery. Virtual Presentation, US.
2021. Multicenter Collaboration on Advances in Intraoperative Fluorescence Imaging in Thyroidectomy and Parathyroidectomy Surgery: A Panel Discussion, Cleveland Clinic Innovations in Endocrine Surgery Webinar Series. Invited. Cleveland Clinic Endocrinology & Metabolism Institute. Virtual Presentation, US.
2021. Parathyroid Autofluorescence in Thyroid Surgery, Cleveland Clinic Innovations in Endocrine Surgery Webinar Series. Invited. Cleveland Clinic Endocrinology & Metabolism Institute. Virtual Presentation, US.
2021. Novel therapeutics and treatment strategies for advanced thyroid cancer, Cleveland Clinic Head & Neck Institute Grand Rounds. Invited. Cleveland Clinic Head and Neck Institute. Virtual Presentation, US.
2021. Neoadjuvant Clinical Trials for Anaplastic and Medullary Thyroid Cancer. Invited. National Cancer Institute Head & Neck Steering Committee Rare Tumor Task Force. Virtual Presentation, US.
2021. Non-Papillary Endocrine Histologies: poorly differentiated, Medullary Thyroid Cancer, Anaplastic Thyroid Cancer. Invited. American Head and Neck Society Virtual Webinar Series. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time- Hoboken University Medical Center Grand Rounds Presentation, Hoboken, NJ. Invited. Medical Learning Group. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time- Cancer Treatment Centers of America Grand Rounds Presentation, Philadelphia, PA. Invited. Medical Learning Group. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time. Invited. Medical Learning Group Thyroid TeleECHO CME Session. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time - Mount Sinai Hospital Grand Rounds Presentation, Chicago, IL. Invited. Medical Learning Group. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time- SUNY Downstate Medical Center Grand Rounds Presentation, New York, NY. Invited. Medical Learning Group. Virtual Presentation, US.
2020. Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery - Grand Rounds Presentation. Invited. Albert Einstein College of Medicine/Montefiore Medical Center. Virtual Presentation, NY, US.
2020. Salvage Surgery for Recurrent Head & Neck Cancer. Invited. 76th Chilean Congress of Otorhinolaryngology, Medicine and Head and Neck Surgery. Virtual Presentation, US.
2020. Laryngeal Cancer Roundtable. Invited. 76th Chilean Congress of Otorhinolaryngology, Medicine and Head and Neck Surgery. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time - Mount Sinai Hospital Grand Rounds Presentation, Chicago, IL. Invited. Medical Learning Group. Virtual Presentation, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time - Larkin Community Hospital Grand Rounds Presentation, Miami, FL. Invited. Ultimate Medical Academy. Virtual Presentation, FL, US.
2020. Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time. Invited. Medical Learning Group Thyroid TeleECHO CME Session. Virtual Presentation, US.
2020. Molecular Genetic Testing for Thyroid Nodules. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Virtual Presentation, US.
2020. Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery, Grand Rounds Presentation. Invited. University of Southern California Los Angeles. Virtual Presentation, US.
2020. Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systematic Therapy with Surgery. Invited. American Thyroid Association Spring Meeting 2020. Virtual Presentation, US.
2020. Anaplastic Thyroid Cancer in 2020: The Emerging Role of Neoadjuvant Therapy and Surgery for BRAF-mutated Disease. Invited. American Academy of Clinical Endocrinology. Master Class Series. Virtual Presentation, US.
2019. Considerations of Neck Dissection in Thyroid Cancer. Invited. American Thyroid Association - E. Chester Ridgway Trainee Conference. Chicago, IL, US.
2019. Medullary Thyroid Cancer: Extent of Surgery and Postoperative Risk Stratification. Conference. Thyroid Cancer Survivors’ Association. Denver, CO, US.
2019. Medullary Thyroid Case Discussion. Conference. Thyroid Cancer Survivors’ Association. Denver, CO, US.
2019. Anaplastic and Medullary Thyroid Cancer: Integration of Systemic Therapy with Surgery. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. New Orleans, LA, US.
2019. A Video Review of Critical Maneuvers in Thyroid Surgery. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. New Orleans, LA, US.
2019. Molecular Genetic Testing for Thyroid Nodules. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. New Orleans, LA, US.
2019. Introduction to thyroid cancer: Is there an epidemic of thyroid cancer?. Conference. Thyroid Cancer Survivors' Association. New Orleans, LA, US.
2019. Central Neck Dissection for Thyroid Cancer. Invited. American Head and Neck Society Thyroid and Parathyroid Surgery Course for Residents and Fellows. Austin, TX, US.
2019. Debates in Thyroid Cancer: Lobectomy versus Total Thyroidectomy. Invited. American Society of Clinical Endocrinologists. Los Angeles, CA, US.
2019. AACE Medicine-Surgical Collaborative Thyroid Cancer Panel. Invited. American Association of Clinical Endocrinologists. Los Angeles, CA, US.
2018. Cutting Edge Endocrine Surgery: A Case-Based Review of Recent Advances in Endocrine Surgery. Conference. American College of Surgeons Clinical Conference 2018. Boston, MA, US.
2018. Surgery and adjuvant therapy treatment strategies for medullary thyroid cancer. Conference. Thyroid Cancer Survivors’ Conference 2018. Chicago, IL, US.
2018. Maximizing Heart Minimizing Headache in Global Outreach. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Atlanta, GA, US.
2018. Establishing Competency Metrics in Humanitarian Medical Session. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Atlanta, GA, US.
2018. Thyroid Cancer Epidemiology and Treatment Patterns. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Atlanta, GA, US.
2018. Otolaryngology Outreach: Critical Appraisal by African Recipients of Outreach. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Atlanta, GA, US.
2018. AJCC 8th edition Staging for Head & Neck and Thyroid Cancer. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Atlanta, GA, US.
2018. Management of Thyroid Cancer in the Lateral Neck. Invited. Combined Otolaryngology Spring Meeting (COSM). National Harbor, MD, US.
2017. Medullary Thyroid Cancer: To Perform or Not Perform Lateral Neck Dissection. Controversies in the Surgical Management of Thyroid Cancer (Moderators: Tufano R and Parangi S). Invited. American College of Surgeons 2017 Clinical Congress. San Diego, CA, US.
2017. Discussant for the Owen H. Wangensteen Scientific Forum: Medullary Thyroid Cancer. Invited. American College of Surgeons 2017 Clinical Congress. San Diego, CA, US.
2017. Medullary Thyroid Cancer: A Surgeon’s Perspective on Surgery, Revision Surgery, Watchful Waiting, and Adjuvant Therapy. Invited. Thyroid Cancer Survivors Conference. Baltimore, MD, US.
2017. Is there a Thyroid Cancer Epidemic?. Invited. American Academy of Otolaryngology-Head and Neck Surgery Thyroid Cancer Survivors Association Conference. Chicago, IL, US.
2017. Collaborative Educational Efforts in Head and Neck Surgery in East Africa. Miniseminar Panel: Developing a Sustainable Medical Outreach Program. Zender C, Netterville J, Fagan J, Otiti J, Zafereo M. Invited. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Chicago, IL, US.
2017. Video Review of Lateral Neck and Retropharyngeal Surgery. Miniseminar Panel: Video Review of Critical Maneuvers in Thyroid Surgery. Singer M, Tufano R, Shindo M, Wong R, Terris D, Cernea C, Zafereo M. Invited. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Chicago, IL, US.
2017. Head & Neck Endocrine Surgery as a Career: Subspecialization in Academic Medicine. Miniseminar Panel: Endocrine Surgery as a Career. Tufano R, Randolph G, Eisele D, Sinclair C, Duke W, Singer M, Rhode S, Lango M, Zafereo M. Invited. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Chicago, IL, US.
2017. Invasive Thyroid Cancer. Invited. American Head and Neck Society Thyroid and Parathyroid Surgery Course for Residents and Fellows. San Diego, CA, US.
2017. Medullary Thyroid Cancer: How has Management Changed? In: Jatin P Shah Symposium: Aggressive Thyroid Malignancies: State of the Art Management. Invited. American Head and Neck Society Combined Otolaryngology Spring Meeting. San Diego, CA, US.
2016. Surgery and Postoperative Risk Assessment with Medullary Thyroid Cancer. Invited. Thyroid Cancer Survivors Conference. Los Angeles, CA, US.
2016. Prognostic Factors in Surgical Patients with Sporadic Medullary Thyroid Cancer. Conference. 86th American Thyroid Association Annual Meeting. Denver, CO, US.
2016. Hurthle Cell Carcinoma: A 19-year Clinical Experience. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. San Diego, CA, US.
2016. The Thyroid Cancer 'Epidemic'. Conference. American Academy of Otolaryngology-Head and Neck Surgery Foundation 2016 Annual Meeting & ThyCa Thyroid Cancer Survivors' Association Patient Education Seminar. San Diego, CA, US.
2016. Reirradiation Utilizing Proton Radiation Therapy May Improve Toxicity Free Survival in Patients With Small-Volume, Recurrent Head And Neck Cancer. Invited. 2016 American Society for Radiation Oncology (ASTRO) Annual Meeting. Boston, MA, US.
2015. Practice guidelines in developing countries: listening and consensus building vs paternalistic advice. Invited. American Head and Neck Society 2015 Annual Meeting. Boston, MA, US.
2014. Avoiding the Deadly Sins of Humanitarian Missions: How to Do Good Better. Invited. Miniseminar American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Orlando, FL, US.
2010. Surgical management of mandibular osteoradionecrosis. Conference. 2010 Combined Otolaryngology Society Meeting. Las Vegas, NV, US.
2010. FAS and FASL genetic variants as predictors of survival and risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Conference. Combined Otolaryngology Society Meeting. Las Vegas, NV, US.
2009. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. San Diego, CA, US.
2009. IGF polymorphisms and thyroid cancer. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. San Diego, CA, US.
2009. The influence of timing and previous radiation on complications and speech outcomes with tracheoesophageal prostheses. Conference. Combined Otolaryngology Society Meeting. Phoenix, AZ, US.
2009. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Conference. American Association for Cancer Research Annual Meeting. Denver, CO, US.
2009. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Conference. American Association for Cancer Research Annual Meeting. Denver, CO, US.
2008. Oropharyngeal Reconstruction Following Oncologic Resection. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Chicago, IL, US.
2008. Supraglottoplasty for Laryngomalacia with Sleep Apnea. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Chicago, IL, US.
2007. Esthesioneuroblastoma: 25-year experience at a single institution. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Washington, DC, US.
2004. Pneumatosis Coli – A Rare Manifestation of Severe Ulcerative Colitis Heralding Impending Perforation without Acute Abdomen in an Immunosuppressed Patient. Conference. American College of Gastroenterology Annual Meeting. Orlando, FL, US.

International Presentations

2024. New Technologies and Treatment Strategies in Head and Neck and Thyroid Cancer. Invited. Confederation of European ORL - HNS Annual Meeting. Dublin, IE.
2024. Neoadjuvant Targeted Therapy and Immunotherapy Prior to Surgery for Advanced Thyroid Cancer. Invited. Confederation of European ORL - HNS Annual Meeting. Dublin, IE.
2024. AAO-HNS American Academy of Otolaryngology - Head and Neck Surgery. Invited. Confederation of European ORL - HNS Annual Meeting. Dublin, IE.
2024. Integration of Targeted Therapy and Surgery for Advanced Thyroid Cancer. Invited. 95th German Society of Otohyinolaryngology, Head and Neck Surgery Annual Meeting. Essen, DE.
2024. International Forum: Oropharyngeal Carcinoma. Invited. 95th German Society of Otorhinolaryngology, Head and Neck Surgery Annual Meeting. Essen, DE.
2024. Update on Salivary Gland Neoplasms. Invited. Mexico Otolaryngology Meeting 2024. Guadalajara, MX.
2024. Comprehensive Management of Oral Cavity Cancer. Invited. Mexican Otolaryngology Meeting 2024. Guadalajara, MX.
2024. Thyroid Cancer and Neoplasms: Surgery and Beyond. Invited. Mexican Otolaryngology Meeting 2024. Guadalajara, MX.
2024. TEMA: Management of the Tumoral Pathologies of the Skull Base. Invited. Mexcian Otolaryngology Annual Meeting 2024. Guadalajara, MX.
2024. The MMM Score: Validating a Novel Clinical and Radiographic Scoring System to Quantify Thyroid Cancer Local Invasion. Invited. International Thyroid Oncology Group (ITOG). Jacksonville, US.
2024. Neoadjuvant Treatment with Selpercatinib in RET-Altered. Invited. International Thyroid Oncology Group (ITOG). Jacksonville, US.
2023. Clinical Cases: Final Considerations. Invited. Next Frontiers To Cure Cancer 2023. Virtual Presentation, BR.
2023. Guidelines Update: Towards a Common Global Standard. Invited. World Congress on Thyroid Cancer (WCTC), GB.
2023. Management of Advanced Differentiated Thyroid Cancer 2023. Invited. World Congress on Thyroid Cancer (WCTC), GB.
2023. Management of the Airway in Locally Invasive Thyroid Cancer: the Role of Neoadjuvant Therapy and Surgery. Invited. World Congress on Thyroid Cancer (WCTC), GB.
2023. A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer. Conference. World Congress on Thyroid Cancer (WCTC), GB.
2023. Surgery for Thyroid Cancer 2023 Symposium. Invited. World Congress on Thyroid Cancer (WCTC), GB.
2023. Advances in Anaplastic Thyroid Cancer Management. Invited. World Congress on Thyroid Cancer (WCTC), GB.
2023. Neoadjuvant Treatment with Selpercatinib in RET-altered Thyroid Cancers. Invited. International Thyroid Oncology Group Annual Meeting. Hybrid Virtual, IT.
2023. International Thyroid Tumor Board - VIRTUAL. Invited. THANC (Thyroid, Head and Neck Cancer) Foundation. New York, US.
2023. Keynote Speaker: Poorly Differentiated and Anaplastic Thyroid Cancer: Controversies and Aggressive Management. Invited. International Federation of Otorhinolaryngological Societies (IFOS), AE.
2023. Practical Guidelines in Low Resource Settings in Head and Neck Surgery. Invited. International Federation of Otorhinolaryngological Societies (IFOS), AE.
2023. Thyroid Cancer: Controversies and Aggressive Management. Invited. International Federation of Otorhinolaryngological Societies (IFOS), AE.
2023. Keynote Speaker: The Integration of Targeted Therapy and Surgery in Advanced Thyroid Cancer Clinical Trials. Invited. International Federation of Otorhinolaryngological Societies (IFOS), AE.
2022. Update in the Management of Anaplastic Thyroid Cancer. Invited. International Conference of the Korean Society for Head & Neck Oncology 2022. Hybrid Meeting w/ Virtual Lecture.
2022. Multidisciplinary Management of Thyroid Cancer: Surgery & Beyond. Invited. H. University Principe de Asturias - Third Endocrine Surgery Annual Meeting: Advances in Thyroid Surgery. Hybrid Meeting w/ Virtual Lecture, ES.
2022. Panel Discussion: Strategies to Reduce Thyroid Cancer Recurrence. Invited. 52nd Brazilian Congress Otorhinolaryngology-Head & Neck Surgery, BR.
2022. Strategies to Reduce Thyroid Cancer Locoregional Recurrence. Invited. 52nd Brazilian Congress Otorhinolaryngology-Head & Neck Surgery, BR.
2022. Multidisciplinary Management of Advanced Laryngeal Cancer. Invited. 52nd Brazilian Congress Otorhinolaryngology-Head & Neck Surgery, BR.
2022. Technology in Thyroid Surgery. Invited. 52nd Brazilian Congress Otorhinolaryngology-Head & Neck Surgery, BR.
2022. Genetic Molecular Profuling and Therapy for Advanced Thyroid Cancer: Next Frontier to Cure Cancer Conference. Invited. AC Camargo Cancer Center. Virtual Presentation, BR.
2022. Genetic Molecular Profuling and Therapy for Advanced Thyroid Cancer. Invited. 93rd Annual Meeting of the German Society of Oto-Rhino-Laryngology Head & Neck Society, DE.
2022. Neoadjuvant Selpercatinib for RET-altered Thyroid Cancer. Invited. International Thyroid Oncology Group 2022 Annual Meeting. Virtual Presentation, US.
2022. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer. Invited. International Thyroid Oncology Group 2022 Annual Meeting. Virtual Presentation, US.
2022. Meet the Professors: Anaplastic Thyroid Cancer. Invited. World Congress on Thyroid Cancer 2022. VIRTUAL, US.
2021. Management of the Central Compartment: Surgical Strategy and Beyond. Invited. 4th Brazilian (SIADTI) International Symposium on the Treatment of Thyroid Disease. Virtual Presentation, US.
2021. Locally Advanced and Metastatic Thyroid Cancer. Invited. 4th World Thyroid Cancer Congress. Virtual Meeting, US.
2021. International Primer Course on Endocrine Surgery, Thyroid/Parathyroid Tumor Board Panel. Invited. 2021 AHNS International Conference on Head and Neck Cancer. Virtual Presentation, US.
2021. Neoadjuvant BRAF/MEK inhibition and immunotherapy for BRAF-mutated Anaplastic Thyroid Cancer. Invited. International Thyroid Oncology Group 2021 Annual Virtual Meeting. Virtual Presentation, US.
2021. Neoadjuvant Selpercatinib for RET-altered Thyroid Cancer. Invited. International Thyroid Oncology Group 2021 Annual Virtual Meeting. Virtual Presentation, US.
2021. Neoadjuvant targeted therapy strategies with surgery for advanced thyroid cancer. Invited. International Congress of ORL-HNS 2021; 95th Annual Congress of Korean Society of OTO-HNS. Virtual Presentation.
2021. Neoadjuvant Clinical Trials for Anaplastic and Medullary Thyroid Cancer: Integration of Targeted Therapy with Surgery. Invited. International Congress of ORL-HNS 2021; 95th Annual Congress of Korean Society of OTO-HNS. Virtual Presentation.
2021. New Therapeutics and Treatment Strategies for Anaplastic and Medullary Thyroid Cancer, London, England. Invited. Royal College of Physicians, 2nd New Developments and Controversies in the Management of Thyroid Cancer. Virtual Presentation, GB.
2021. Locally Advanced Thyroid Disease Roundtable, London, England. Invited. Royal College of Physicians, 2nd New Developments and Controversies in the Management of Thyroid Cancer. Virtual Presentation, GB.
2020. Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery. Invited. V Jornadas Cáncer de Cabeza y Cuello 2020. Virtual Presentation, VE.
2020. Surgery for Differentiated Thyroid Cancer. Invited. 50th Brazilian Conference of Otolaryngology-Head & Neck Surgery. Virtual Presentation, BR.
2020. Anaplastic Thyroid Cancer in 2020: The Emerging Role of Neoadjuvant Therapy and Surgery for BRAF-mutated Disease. Invited. Tarabichi-Stammberger Ear and Sinus Institute (Dubai). Virtual Presentation, AE.
2020. Thyroid Nodules and Differentiated Thyroid Cancer in 2020. Invited. Tarabichi-Stammberger Ear and Sinus Institute (Dubai). Virtual Presentation, AE.
2020. Staging and Surgery for Differentiated Thyroid Cancer in 2020. Invited. VIII Thyroid Cancer International Meeting 2020. São Paulo, BR.
2020. Medullary Thyroid Cancer: Extent of Surgery and Postoperative Risk Stratification. Invited. VIII Thyroid Cancer International Meeting 2020. São Paulo, BR.
2020. Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery. Invited. VIII Thyroid Cancer International Meeting 2020. São Paulo, BR.
2020. Thyroid Cancer Epidemiology and Treatment Strategies in 2020. Invited. XXXII Annual Vozandes Hospital Diseases of the Head & Neck Conference. Quito, EC.
2020. Multidisciplinary Thyroid Cancer Expert Panel and Case Discussion. Invited. XXXII Annual Vozandes Hospital Diseases of the Head & Neck Conference. Quito, EC.
2020. Thyroid Molecular Genetic Testing and Surgery for Differentiated Thyroid Cancer in 2020. Invited. XXXII Annual Vozandes Hospital Diseases of the Head & Neck Conference. Quito, EC.
2019. Medullary Thyroid Cancer in 2019: Extent of Surgery and Postoperative Risk Stratification Panel. Invited. XXVII Brazilian Congress of Head & Neck Surgery. Gramado, BR.
2019. Management of Differentiated Thyroid Cancer Panel. Invited. XXVII Brazilian Congress of Head & Neck Surgery. Gramado, BR.
2019. Integrating Systemic Therapy and Surgery for Medullary Thyroid and Anaplastic Thyroid Cancer. Invited. XXVII Brazilian Congress of Head & Neck Surgery. Gramado, BR.
2019. Management of grossly invasive thyroid cancer panel. Invited. 5th Congress of European ORL-HNS 2019. Brussels, BE.
2019. Pediatric Thyroid Cancer Instructional Course. Invited. 5th Congress of European ORL-HNS 2019. Brussels, BE.
2019. New Hope for Anaplastic Thyroid Cancer in 2019. Invited. 5th Congress of European ORL-HNS 2019. Brussels, BE.
2019. Anaplastic Thyroid Cancer Management: The Evolving Role of Targeted Therapy and Surgery. Invited. World Congress on Thyroid Cancer 2019. Rome, IT.
2019. Medullary Thyroid Cancer and the Neck - Expert Case Discussion. Invited. World Congress on Thyroid Cancer 2019. Rome, IT.
2019. Medullary Thyroid Cancer: Surgery and Beyond. Invited. Tel Aviv Sourasky Medical Center Department of Otolaryngology. Tel-Aviv, IL.
2019. Anaplastic Thyroid Cancer. Invited. Tel Aviv Sourasky Medical Center Department of Otolaryngology. Tel Aviv, IL.
2019. Complicated Case & Thyroid Cancer Multidisciplinary Case Discussion. Invited. Tel Aviv Sourasky Medical Center Department of Otolaryngology. Tel Aviv, IL.
2019. Approaches to initial therapy for IVA/B Anaplastic Thyroid Cancer. Invited. International Thyroid Oncology Group Meeting 2019. New York, US.
2018. New Hope for Surgery for Anaplastic Thyroid Cancer in the Era of Targeted Therapy | New Hope for Surgery Cojoint Panel. Invited. Asian Pacific Society of Thyroid Surgery. Kaohsiung, TW.
2018. Thyroid Cancer: Update 2018. Invited. Pan American Congress of Otorhinolaryngology and Head & Neck Surgery. Lima, PE.
2018. Technological Advancements in the Treatment of Thyroid Neoplasms. Invited. Pan American Congress of Otorhinolaryngology and Head & Neck Surgery. Lima, PE.
2018. Global Otolaryngology 2018: Your Academy Around the World. Invited. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Atlanta, US.
2018. Keynote Speaker: New Hope for Anaplastic Thyroid Cancer In The Era Of Targeted Therapy. Invited. 20th Annual Meeting Australian and New Zealand Head & Neck Cancer Society (ANZHNCS). Melbourne, AU.
2018. Keynote Speaker: Changes in Treatment Patterns for Medullary Thyroid Cancer. Invited. 20th Annual Meeting Australian and New Zealand Head & Neck Cancer Society (ANZHNCS). Melbourne, AU.
2018. Keynote Speaker: Techniques for Managing Locoregionally Advanced Thyroid Cancer. Invited. 20th Annual Meeting Australian and New Zealand Head & Neck Cancer Society (ANZHNCS). Melbourne, AU.
2018. Providing Head and Neck Cancer Care in the Developing World. Invited. 20th Annual Meeting Australian and New Zealand Head & Neck Cancer Society (ANZHNCS). Melbourne, AU.
2018. Thyroid Cancer: Surgery and Beyond. Invited. 2nd African Head and Neck Society (AfHNS) Annual Scientific Conference. Accra, GH.
2018. Medullary Thyroid Cancer: Surgery and Beyond. Invited. Les Entretiens Otorhinolaryngologiques 2018- Université de Montréal. Montreal, CA.
2018. New Hope for Anaplastic Thyroid Cancer In The Era Of Targeted Therapy. Invited. Les Entretiens Otorhinolaryngologiques 2018- Université de Montréal. Montreal, CA.
2017. 2017 update for oral cavity and oropharyngeal squamous cell carcinoma. Invited. Tanzania ENT Society 2017 Congress. Zanibar, TZ.
2017. Surgical anatomy, technique, and comprehensive management of parotid, larynx, and lateral neck neoplasia. Invited. Muhimbili University. Dar Es Salaam, TZ.
2017. Surgery and Adjuvant Therapy for Locoregionally Advanced Medullary Thyroid Cancer. Invited. Asian Pacific Thyroid 2nd Congress. Okinawa, JP.
2017. Epidemiology and Management of Papillary Thyroid Microcarcinoma. Invited. Asian Pacific Thyroid 2nd Congress. Okinawa, JP.
2017. Evaluation and Management of Poorly Differentiated, Anaplastic, and Agressive Variants of Thyroid Cancer. Invited. 3rd World Congress on Thyroid Cancer. Boston, US.
2017. Parathyroid & Thyroid Panel. Thyroid Nodule and Thyroid Cancer Primer. Invited. 3rd World Congress on Thyroid Cancer. Boston, US.
2017. Symposium: Humanitarian Missions in Africa: A Critical Review of What Does and Doesn't Work. Invited. International Federation of Otohinolaryngological Societies ENT World Congress. Paris, FR.
2017. Rountable Session: Salvage Surgery. Invited. International Federation of Otohinolaryngological Societies ENT World Congress. Paris, FR.
2016. Thyroid Surgery Anatomy and Technique. Conference. Tanzanian ENT Society Congress. Mwanza, TZ.
2016. International Symposia on Thyroid Cancer Panel. Conference. UAE Cancer Congress. Dubai, AE.
2016. International Activities Task Force and International Advisory Board Panel. Conference. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. San Diego, US.
2016. Thyroid Cancer Guidelines 2016 around the World Miniseminar. Conference. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting. San Diego, US.
2016. Management of the lateral neck compartment in patients with sporadic medullary thyroid carcinoma. Conference. AHNS 9th International Conference on Head and Neck Cancer. Seattle, US.
2016. State of the Art Treatment for Head and Neck Cancer 2016. Invited. 35th PanAmerican Congress. Havana, CU.
2016. Treatment Debate: Minimally Invasive Thyroid Surgery. Conference. 35th PanAmerican Congress. Havana, CU.
2015. Parotid Neoplasia and Surgical Techniques. Invited. Tanzanian ENT Society 2015 Annual Meeting. Moshi, TZ.
2015. Larynx Cancer and Surgery. Invited. Ocean Road Cancer Institute. Dar Es Salaam, TZ.
2015. Neck Dissection: Historical Perspective, Indications and Techniques. Invited. Ocean Road Cancer Institute. Dar Es Salaam, TZ.
2015. Parotid Cancer and Surgery. Invited. Ocean Road Cancer Institute. Dar Es Salaam, TZ.
2015. 2015 American Thyroid Association Guidelines. Conference. 3rd Congress of European ORL-HNS. Prague, CZ.
2015. Moderator, Miniseminar Panel, Differences in national thyroid nodule and thyroid cancer guidelines among countries in Europe and North America. Conference. 3rd Congress of European ORL-HNS. Prague, CZ.
2015. Moderator, Miniseminar Panel, Non-Squamous Cell Tumors of the Head and Neck. Conference. 3rd Congress of European ORL-HNS. Prague, CZ.
2015. Moderator, Miniseminar Panel, Controversies and challenges in the management of thyroid cancer. Conference. 3rd Congress of European ORl-HNS. Prague, CZ.
2015. Carotid Body Tumors. Conference. 3rd Congress of European ORL-HNS. Prague, CZ.
2015. Monitoring the Post Chemoradiation Neck. Invited. Pan African Otolaryngology Congress 2015. Luxor, EG.
2015. Guidelines for Surgical Management of Well Differentiated Thyroid Cancer. Invited. Pan African Otolaryngology Congress 2015. Luxor, EG.
2015. Salvage Surgery for Recurrent Oropharyngeal Squamous Cell Carcinoma. Invited. Pan African Otolaryngology Congress 2015. Luxor, EG.
2015. Neck Dissection Classification. Invited. Pan African Otolaryngology Congress 2015. Luxor, EG.
2014. Salvage Surgery for Recurrent Oropharyngeal Carcinoma. Invited. XXXIV Pan American Congress of Otolaryngology Head and Neck Surgery. Cartagena, CO.
2014. Guidelines for surgery for well differentiated thyroid cancer. Invited. XXXIV Pan American Congress of Otolaryngology Head and Neck Surgery. Cartagena, CO.
2014. Salvage surgery for recurrent oropharyngeal and oral cavity squamous cell carcinoma. Invited. Annual Updates on Breakthroughs in Hematology and Oncology. Bangkok, TH.
2014. Surgical Salvage for Recurrent Oral Cavity Squamous Cell Carcinoma. Conference. IFHNOS 5th World Congress and AHNS Annual Meeting. New York, US.
2013. Developing Guidelines for Thyroid Surgery in Varying Resource Settings in Africa. Invited. Africa Organization for Research and Training in Cancer. Durban, ZA.
2013. Global Health 2013: Academy Around the World. Invited. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting. Vancouver, CA.
2012. Thyroid Cancer in Africa. Invited. All Africa ENT and American Academy of Otolaryngology Congress. Victoria Falls, ZW.
2012. Local Flaps in Head and Neck Reconstruction. Invited. All Africa ENT and American Academy of Otolaryngology Congress. Victoria Falls, ZW.
2008. The Role of Salvage Surgery in Recurrent Oropharyngeal Squamous Cell Carcinoma. Conference. 7th International Conference on Head and Neck Cancer. San Francisco, US.
2008. Oral Cavity Cancer in Young Patients: Evidence of an Association with HPV16. Conference. 7th International Conference on Head and Neck Cancer. San Francisco, US.

Formal Peers

2024. Targeted therapy and surgery for advanced thyroid cancer. Invited. Shin Kong Wu Ho-Su Memorial Hospital, Taiwan. Virtual, TW.
2024. Surgery for Advanced Thyroid Cancer in the Era of Targeted Systemic Therapy. Invited. UAB - University of Alabama in Birmingham. Birmingham, AL, US.
2024. Targeted Therapy and Surgery for Advanced Differentiated Thyroid Cancer. Invited. Lenox Hill / Manhattan Eye and Ear Hospitals. New York, NY, US.
2022. Management of Locoregionally Advanced Thyroid Cancer. Invited. The Lurie Cancer Center - Northwestern University. Chicago, IL, US.
2022. Visiting Professor: Integration of Surgery and Targeted Systemic Therapy in Modern Advanced Thyroid Cancer Clinical Trials. Visiting. Cedar-Sinai Thyroid Cancer Grand Rounds. Virtual Presentation, CA, US.
2021. Visiting Professor: Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery. Visiting. Memorial Sloan Kettering Cancer Center Multidisciplinary Grant Round. Virtual Presentation, US.
2020. The integration of systemic therapy and surgery for anaplastic and medullary thyroid cancer. Invited. Thyroid Head & Neck Cancer (THANC) Foundation/Thyroid Care Collaborative/University of Mount Sinai. New York, NY, US.
2019. Visiting Professor: Medullary Thyroid Cancer: Surgery And Beyond. Visiting. AC Camargo Cancer Center. São Paulo, BR.
2019. Visiting Professor | New Hope for Anaplastic Thyroid Cancer in the Age of Neoadjuvant Therapy and Surgery. Visiting. AC Camargo Cancer Center. São Paulo, BR.
2019. Visiting Professor | Differentiated Thyroid Cancer 2019. Visiting. Tel Aviv Sourasky Medical Center Department of Otolaryngology. Tel Aviv, IL.
2018. The evolving role of external beam radiation therapy in the treatment of aggressive thyroid cancers. Invited. Thyroid Head & Neck Cancer (THANC) Foundation/Thyroid Care Collaborative/University of Mount Sinai. New York, NY, US.
2018. Visiting Professor and Instructor. Visiting. Korle Bu Teaching Hospital. Accra, GH.
2018. Visiting Professor. Visiting. University of Montreal. Montreal, CA.
2017. Visiting Professor and Instructor. Visiting. Muhimbili University. Dar Es Salaam, TZ.
2016. Visiting Professor. Visiting. Muhimbili University. Dar Es Salaam, TZ.
2016. Visiting Professor. Visiting. Bugando Catholic University Medical Center. Mwanza, TZ.
2016. Visiting Professor and Grand Rounds. Medullary Thyroid Cancer: Surgery and Beyond. Visiting. Baylor College of Medicine. Houston, TX, US.
2015. Visiting Professor and Instructor. Head and Neck Surgery Workshop. Visiting. Tanzanian Society 2015 Annual Meeting. Moshi, TZ.
2013. Visiting Professor and Instructor. Neck and Parotid Surgery Workshop (in Conjunction with 2013 Tanzanian ENT Society Meeting). Visiting. Muhimbili University of Health and Allied Sciences, Muhimbili National Referral Hospital. Dar Es Salaam, TZ.
2013. Visiting Professor and Instructor. Thyroid, Salivary Gland Neoplasm and Neck Dissection Workshop. Visiting. Makerere University and Mulago National Referral Hospital. Kampala, UG.
2012. Visiting Professor and Instructor. Thyroid Surgery Workshop. Visiting. King Faisel Hospital. Kigali, RW.
2012. Visiting Professor and Grand Rounds. Well Differentiated Thyroid Cancer: Surgery and Beyond. Visiting. University of Maryland. College Park, MD, US.
2011. Visiting Professor and Instructor. Pectoralis Flaps in Head and Neck Reconstruction Workshop. Visiting. Muhimbili University of Health and Allied Sciences, Muhimbili National Referral Hospital. Dar Es Salaam, TZ.

Less

Grant & Contract Support

Title:	Statistical methods for genomic analysis of heterogeneous tumors
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Lenvatinib in combination with pembrolizumab for stage IVB locally advanced and unresectable or stage IVC metastatic anaplastic thyroid cancer
Funding Source:	Merck MISP Program
Role:	Co-PI

Title:	Pembrolizumab in combination with dabrafenib and trametinib as a neoadjuvant strategy prior to surgery therapy in BRAF-mutated anaplastic thyroid cancer
Funding Source:	Merck
Role:	PI

Title:	Neoadjuvant/Adjuvant Treatment with Selpercatinib in RET-Altered Thyroid Cancers
Funding Source:	Lilly USA
Role:	PI

Title:	Targeted Therapy Combined with Pembrolizumab in Anaplastic Thyroid Cancer: Two Phase II Clinical Trials
Funding Source:	Gateway Cancer Research
Role:	PI

Title:	Intratumor Heterogeneity in Anaplastic Thyroid Carcinoma: Implications for Treatment Resistance
Funding Source:	The Mark Foundation for Cancer Research, ASPIRE Grant
Role:	Co-PI

Title:	Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules
Funding Source:	GenePro Diagnostics
Role:	PI

Title:	NO TITLE PROVIDED
Funding Source:	Roche
Role:	Collaborator

Title:	Establishing Dietary Correlates of IGF-1 Ligand Expression in Cancer patients
Funding Source:	Riviera Country Club, Orland Park, Illinois
Role:	Collaborator

Title:	Molecular Relapse Detection and Surveillance in Non-Surgical Head & Neck Cancer Patients
Funding Source:	Other
Role:	PI

Title:	Microscopic Residual Disease Detection and Surveillance in Resectable Head & Neck Cancer
Funding Source:	Other
Role:	PI

CV information above last modified February 13, 2025

Mark E. Zafereo, M.D., F.A.C.S.

About Dr. Zafereo

In the News

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Abstracts

Book Chapters

Books (edited and written)

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Head and Neck Surgery Department

Endocrine Center

Help #EndCancer

Mark E. Zafereo, M.D., F.A.C.S.

About Dr. Zafereo

In the News

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Abstracts

Book Chapters

Books (edited and written)

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Head and Neck Surgery Department

Endocrine Center

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer